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ABSTRACT
Introduction: Pregnancy is a state of naturally occurring insulin resistance; with
hyperglycaemia being associated with maternal and foetal risk for adverse outcomes.
For women with a healthy pregnancy, Australian guidelines recommend regular
moderate intensity exercise. However, many pregnant women report significant
barriers for regular exercise participation, including misconceptions with respect to the
safety of engaging in moderate and higher intensities of exercise. Interval exercise at
high intensity is efficacious for glycaemic control in people with metabolic conditions
such as type 2 diabetes. Yet in pregnancy, the effectiveness of a bout of interval
(discontinuous) exercise on enhancing daily glycaemic control has not yet been
investigated. Aim: This study investigated the effects of two different structured bouts
of acute cycling (discontinuous with intermittent rest period vs. continuous) on acute
cardiometabolic responses and 24-hour glycaemic responses in pregnant and nonpregnant women. Methods: Fourteen pregnant and non-pregnant women completed
two exercise trials completed in a non-randomised format over consecutive weeks,
with either a 30-minute bout of continuous or discontinuous exercise, matched for total
external work. Acute cardiometabolic responses to exercise were measured
immediately prior to, during and immediately after exercise, including blood glucose
(BGL), expired gas exchange (oxygen consumption, respiratory exchange ratio and
minute ventilation), and heart rate variability. Daily glycaemic responses were
measured by continuous glucose monitor over 48-hours (24 hours either side of the
exercise bout). Dietary and physical activity patterns were standardised between each
48-hour collection period. Results: Baseline BGL did not differ between pregnant and
non-pregnant women and were within the clinically normal range. A significant
interaction between exercise type and acute BGL changes immediately post-exercise
was observed in pregnant and non-pregnant participants. In pregnant women,
discontinuous exercise acutely lowered BGL by 4.8%, from 5.67mmol.L-1 (with 95% CI
5.24,6.10) to 5.40mmol.L-1 (4.82,5.97) (p= 0.008); while continuous exercise lowered BGL
by 4.9%, from 5.24mmol.L-1 (4.85,5.63) to 4.98mmol.L-1 (4.59,5.38) (p= 0.020). In non-
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pregnant women, acute BGL lowered by 8.2% after continuous exercise (5.58mmol.L-1
[4.62,6.55] to 5.16mmol.L-1 [4.39,5.81]) (p = 0.012); but only 1.8% after discontinuous
exercise, which did not reach significance (5.60mmol.L-1 [5.05,6.15] to 5.50mmol.L-1
[5.01,5.99]) (p= 0.175). Neither discontinuous (p= 0.81) or continuous (p= 0.21) exercise
resulted in a significant interaction between 24h glycaemic responses and pregnancy
condition. Similarly, there were no interactions observed for other cardiometabolic
measures obtained during exercise, being heart rate variability differences that could
reflect sympathetic and parasympathetic modulation, or metabolic measures that could
reflect substrate utilisation during exercise. Conclusion: A bout of discontinuous,
moderate intensity exercise totaling 15 min was equivalent to exercising for 30 minutes
continuously at low intensity exercise for effects observed on acute post-exercise BGL
response in pregnant participants. However, neither bout resulted in changes to
measures of daily blood glucose control; nor differences in other cardiometabolic
measures that could reflect differences of interval-structured exercise effect in pregnant
participants. Further research is needed to identify a discontinuous exercise dose that
augments daily glycaemic control in pregnancy and is well tolerated by pregnant
women for regular participation in line with pregnancy recommendations.
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1.

THE ROLE OF ACUTE EXERCISE IN ENHANCING GLYCAEMIC CONTROL
IN PREGNANCY

Regular exercise is strongly recommended during pregnancy for gestational health, including
the management of glycaemic control and metabolic health (Artal 2015, Harrison, Shields et al.
2016, Hayman, Brown et al. 2016). Recently updated Australian recommendations advocate
for regular moderate intensity exercise as the minimum level for women with a healthy,
uncomplicated pregnancy (Hayman, Brown et al. 2016). Yet pregnant women face barriers for
regular exercise participation, including adverse pregnancy symptoms (fatigue, nausea,
mobility, comfort), a lack of confidence to commence or continue exercise safely during
pregnancy, and uncertainty of benefit of doing exercise and moderate (or higher) intensities.
These barriers, in part, contribute to 60-70% women being insufficiently active for health
benefits. (Evenson and Bradley 2010, Cioffi, Schmied et al. 2010, Gjestland, Bø et al. 2013, Sui,
Turnbull et al. 2013, Coll, Domingues et al. 2017). Recent reviews identified that women’s
regular exercise participation reduces in pregnancy compared to pre-pregnancy, and further
reduces with advancing gestation (Poudevigne and O'Connor 2006, Gaston and Cramp 2011) .
Furthermore, the intensity, frequency and duration of women’s exercise during pregnancy
commonly decrease compared with pre-pregnancy (Poudevigne and O'Connor 2006, Gaston
and Cramp 2011). This relative reduction in exercise associated with pregnancy and
advancing gestation is counterproductive to the management of metabolic health, as it is in
opposition to the progressive increase in maternal insulin resistance. Given this mismatch
between recommended exercise for pregnancy health, including the management of
hyperglycaemia, and exercise behaviours and beliefs during pregnancy, there is still a clear
need for finding practical and effective exercise strategies to support glycaemic control that
are also acceptable and non-threatening to women during pregnancy.

In non-pregnant persons at-risk of or diagnosed with metabolic dysfunction, exercise
performed as an acute bout or as a chronic training regimen is well established as an effective
treatment to reduce acute hyperglycaemia and improve long term glycaemic control (Boulé,
Weisnagel et al. 2005, Praet, Manders et al. 2006, van Dijk, Tummers et al. 2012, Ruchat and
Mottola 2013, Harrison, Shields et al. 2016, Colberg 2017). As an acute stimulus, exercise
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promotes the uptake of glucose at skeletal muscle through both insulin-mediated and
contractile-mediated (insulin-independent) mechanisms (Burstein, Epstein et al. 1990, Wright,
Hucker et al. 2004, Hawley and Lessard 2008). In type 2 diabetes, skeletal muscle is a key
regulatory tissue affected by peripheral insulin resistance and the adaptive response of
skeletal muscle to acute exercise in type 2 diabetes participants enhances glucose uptake and
insulin sensitivity (Devlin and Horton 1985, Goodyear and Kahn 1998).

Beyond immediate

acute effects following exercise, a single bout of moderate-intensity exercise has also been
shown to significantly improve glycaemic control over a 24-hour period in obese and type 2
diabetic participants (Larsen, Dela et al. 1997, Praet, Manders et al. 2006, Bacchi, Negri et al.
2012, MacLeod, Terada et al. 2013, Van Dijk, Manders et al. 2013, Oberlin, Mikus et al. 2014).
For pregnancy, a naturally occurring diabetogenic state, skeletal muscle has also been
identified as the primary site for peripheral insulin resistance (Leturque, Burnol et al. 1984,
Kuhl 1991, Sorenson and Brelje 1997, Barbour, McCurdy et al. 2007). Therefore, it is important
to identify if an acute bout of exercise in pregnancy will have similar effects on acute glucose
uptake and glycaemic control, that has been established in the type 2 diabetes literature. Early
pregnancy studies have demonstrated exercise-related reductions in blood glucose in the
acute post-exercise period (Bonen, Campagna et al. 1992, Lotgering, Spinnewijn et al. 1998,
Bessinger, McMurray et al. 2002). Surprisingly, there have been no recent investigations
evaluating the effectiveness of any type of acute exercise on blood glucose responses over a
24-hour period; despite the increasing prevalence of gestational diabetes (GDM), and
recognised health risks associated with mild hyperglycaemia levels below GDM diagnostic
thresholds (Waters, Dyer et al. 2016).

In terms of key exercise variables that are important for eliciting positive changes in glycaemic
responses, both exercise intensity and total energy expenditure have been highlighted within
the type 2 diabetes literature (Larsen, Dela et al. 1999, Praet and van Loon 2007, Grace, Chan et
al. 2017). The use of discontinuous exercise structure, commonly referred to as interval
exercise, is a physical loading strategy that allows for intermittent exposure to higher exercise
intensities for a relatively short period of time, followed immediately by a period of rest or
relative rest (light intensity work). The overall benefits of interval exercise, whether acute bout
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or training, have often centred upon demonstrating comparable or advantageous
physiological adaptations to more traditional continuous exercise, but with a reduced total
exercise volume and/or duration needed to achieve the adaptation (Burgomaster, Howarth et
al. 2008, Bartlett, Hwa Joo et al. 2012, Foster, Farland et al. 2015). To apply the interval exercise
concept pregnant women, particularly those who are at higher risk for metabolic dysfunction
such as hyperglycaemia or GDM, there needs to be practical consideration for the reported
barriers to exercise that women experience, such as fatigue, physical discomfort, uncertainly
around commencing exercise during pregnancy for previously inactive women, or uncertainty
around safety of different intensities of exercise during pregnancy. Studies on the effects of
interval exercise in obese or type 2 diabetes participants predominantly use intervals of high
or supra-maximal intensity, commonly termed High Intensity Interval Training/Exercise
(HIIT). There have been no studies at this stage evaluating HIIT in pregnant women for
glycaemic control. Of important consideration is that the safety and acceptability of HIIT for
women not active prior to pregnancy, or who have received a diagnosis of GDM or mild
hyperglycaemia dysfunction, is unknown. Therefore, a discontinuous exercise protocol
performed at moderate intensity would to be an appropriate and practical initial design to
investigate efficacy on glycaemic responses in pregnant women. For the purpose of this thesis,
the term ‘Discontinuous’ will be used when referring to interval exercise that is performed at
moderate intensity, rather than the traditional high intensity design.

Whilst there are clear and beneficial findings when using the highest intensities of exercise in
people who are healthy, or who experience obesity, type 2 diabetes, or metabolic syndrome
(Gibala, Little et al. 2006, Burgomaster, Howarth et al. 2008, Tjonna, Lee et al. 2008, Hood,
Little et al. 2011, Little, Gillen et al. 2011, Bartlett, Hwa Joo et al. 2012, Karstoft, Winding et al.
2014, Little, Jung et al. 2014), there has been little investigation of discontinuous exercise
performed at a lower relative intensity for effects on glycaemic measures, compared to a
continuous exercise protocol To date, there has also been no studies evaluating the effects of
an acute bout of discontinuous exercise of any intensity on any cardiometabolic measures in
pregnant women. Therefore, this study aims to compare the effects of a discontinuous bout of
exercise on glycaemic and cardiometabolic responses in pregnant women, compared to a
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continuous bout of exercise, matched for total work performed. This will also be compared
against a control group of pregnant women, to identify any possible pregnancy-specific
responses that may inform further investigations and future studies. For this study, cycling
was utilised as the mode of exercise primarily as it can be well-controlled for total work,
which facilitates more specific comparison of the effects of continuous versus discontinuous
exercise, and associated intensities, and not the overall energy expenditure of the exercise.
Cycling also removes the influence of bodyweight on metabolic demands of the exercise and
reduces potential issues of mobility and discomfort barriers which are important factors when
investigating pregnant women at different stages of gestation, and different baseline
bodyweights prior to pregnancy.

1.1

Aims and hypotheses:

This study aimed to investigate the effects of a single bout of discontinuous exercise on acute
blood glucose and cardiometabolic exercise responses, and on daily glycaemic control in
pregnant women. This was compared with responses to a bout of continuous exercise,
matched for total work; and both protocols were also conducted in a control group of healthy,
non-pregnant women. It was hypothesised that:
1.

A bout of discontinuous, moderate intensity cycling will elicit comparable acute
glycaemic effects to a bout of continuous, low intensity cycling of matched total work
in pregnant women; with similar responses observed in the non-pregnant control
group.

2.

A

bout

of

discontinuous,

moderate

intensity

cycling

will

elicit

different

cardiometabolic responses during exercise and in the immediate post-exercise recovery
period in pregnant women, compared with continuous, low intensity exercise.
3.

In pregnant women, a bout of discontinuous, moderate intensity cycling will reduce
24-hour blood glucose levels and variability after exercise compared with 24-hours
preceding exercise. Comparatively, there will be no effect observed in pregnant
women following a bout of continuous, low intensity exercise; or in non-pregnant
controls following either discontinuous or continuous protocols.
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A fourth hypothesis (below) was added following data collection and review of the raw 24hour blood glucose data. Both the pregnant and non-pregnant groups were found to be within
normal clinical levels for all measured glycaemic responses, despite the pregnant group
containing four women with diagnosed GDM, and the three non-GDM pregnant women
having characteristics that would increase the likelihood of early peripheral insulin resistance
and maternal hyperglycaemic, being high BMI and inactive prior to and during pregnancy.
Based on there being no difference in baseline blood glucose levels across the participants, an
analysis of pooled data was done to compare the effects of the two exercises, independent of
pregnancy status. This is not the primary focus of the thesis but does allow for further
evaluation of a discontinuous exercise bout done at moderate intensity compared with
continuous, low-intensity exercise.

4. In participants with normal daily glycaemic levels, a bout of discontinuous moderate
intensity cycling will elicit comparable acute and 24-hour blood glucose responses,
compared to a bout of continuous, low intensity exercise of equal total work, but double
the volume of exercise.
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CHAPTER TWO:
REVIEW OF THE RELATED LITERATURE
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2.

REVIEW OF RELATED LITERATURE

This literature review will address several key areas of pregnancy and metabolic physiology
that have been considered when identifying and defining the need and design of this study.
Specific to pregnancy, this includes review of normal and abnormal metabolic changes in
pregnancy; the adverse effects of poor maternal glycaemic control on cardiometabolic
responses in both mother and offspring; the current challenges that beliefs and behaviours of
pregnant women provide in utilising exercise as a strategy for improving glycaemic control;
and the role exercise could play in improving maternal metabolic function. This review also
explores some of the historical and current evidence that has established exercise as an
effective treatment for glycaemic management in other metabolic populations; the dose and
key variables that have been shown to drive glucose uptake and glycaemic regulation; and
lastly to explore the role of interval (versus continuous) exercise, the physiological and
practical benefits reported in the HIIT and SIT literature, and how these concepts may be an
effective strategy for designing exercise to improve glycaemic control in pregnancy.

2.1

Metabolic changes in human pregnancy

During pregnancy, there are significant changes in maternal endocrine, cardiovascular,
respiratory and metabolic functions as a natural adaptation of the gestational process to
support the developing foetus (Lotgering, Gilbert et al. 1985, Clapp, Seaward et al. 1988,
Barbour, McCurdy et al. 2007). The autonomic nervous system is directly implicated in these
functions. Duringpregnancy, resting sympathetic drive is increased which results in relatively
greater sympathetic modulation and lower parasympathetic control (Ekholm, Hartiala et al.
1997, Lucini, Strappazzon et al. 1999, Avery, Wolfe et al. 2001, Maser, Lenhard et al. 2014). At
rest, maternal energy expenditure (oxygen consumption), respiratory demand (minute
ventilation), and cardiac output (as a product of increased heart rate and stroke volume) are
all elevated and continue to increase with advancing gestation (Lotgering, Gilbert et al. 1985,
Artal, Wiswell et al. 1986). Therefore, overall cardiometabolic demands are increased as a
function of normal healthy pregnancy.
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The changes associated with higher metabolic demand and progressive insulin resistance in
pregnancy are complex. Skeletal muscle has been identified as the primary site for maternal
peripheral insulin resistance (Leturque, Burnol et al. 1984, Kuhl 1991). During pregnancy,
resting glucose uptake in skeletal muscle is reduced as a method of conserving circulating
maternal glucose to ensure foetal supply and growth demands are always met (Buchanan,
Metzger et al. 1991, Catalano, Tyzbir et al. 1993, McMurray, Mottola et al. 1993, Catalano,
Huston et al. 1999, Handwerger and Freemark 2000, Bessinger, McMurray et al. 2002, Barbour,
McCurdy et al. 2007). Further, the synchronisation of the sympathetic nervous system and
endocrine systems has significant influence on the maintenance of normal blood glucose at
rest and during exercise (Suh, Paik et al. 2007). Therefore, there is also complex interplay
between sympathetic and endocrine functions during pregnancy in terms of insulin resistance
and glycaemic control.

2.1.1 Importance of glycaemic control
Progressive peripheral insulin resistance over the course of the gestational period is caused by
the normal metabolic effects of circulating pregnancy hormones (Buchanan 1994, Sorenson
and Brelje 1997). When the metabolic challenges of pregnancy trigger declining glycaemic
control and cause maternal hyperglycaemia above the clinical target thresholds for optimal
pregnancy glycaemic control (Nankervis, McIntyre et al. 2013, Waters, Dyer et al. 2016), this is
termed gestational diabetes mellitus (GDM). Gestational diabetes is associated with a number
of obstetric risks, including preeclampsia, infection, caesarean delivery, and post-partum
haemorrhage (Jovanovic and Pettitt 2001, Al-Qahtani, Heath et al. 2012, Lassi and Bhutta
2013). Furthermore, GDM is strongly associated with post-partum metabolic changes that can
advance to chronic metabolic dysfunction in both mother and offspring. There is significantly
elevated maternal risk for progression to type 2 diabetes mellitus and recurrence of GDM in
subsequent pregnancies; and increased risk in offspring for obesity, type 2 diabetes, and GDM
in females in later life (Moses 1996, Kim, Newton et al. 2002, Simeoni and Barker 2009,
Mitanchez, Yzydorczyk et al. 2015). This intergenerational effect of GDM has been identified
as a critical contributor to progressive increases in the prevalence of both obesity and diabetes
(Wild, Roglic et al. 2004, Moore 2010, Artal 2015).
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Importantly, even mild levels of hyperglycaemia in pregnancy without a diagnosis of diabetes
are still correlated with higher risks for adverse maternal and foetal outcomes (Metzger, Lowe
et al. 2008, Moses, Morris et al. 2011, Waters, Dyer et al. 2016). Maternal hyperglycaemia
increases the availability of circulating glucose to the foetus, via facilitated glucose diffusion
across the placenta. Maternal insulin does not cross the placenta, and foetal insulin production
does not occur until the later stages of development, thus maternal hyperglycaemia leads to a
parallel hyperglycaemic state in the foetus, and at later stages, foetal hyperinsulinemia. Inutero, insulin has an important role as a growth hormone; therefore foetal hyperinsulinemia
can potentially contribute to adverse birth outcomes, such as macrosomia, and neonatal
hypoglycaemia (Aerts and Van Assche 2006, Hawdon 2008).

2.2.

Exercise recommendations, beliefs and barriers in pregnancy

Regular exercise is strongly recommended for maternal health, including the prevention and
management of gestational diabetes (Artal 2015, Harrison, Shields et al. 2016, Hayman, Brown
et al. 2016). Recently revised Australian guidelines state that regular exercise performed at
least at moderate intensity is the minimum level recommended for all women with a healthy
pregnancy (Hayman, Brown et al. 2016). For inactive pregnant women, including those who
were inactive prior to pregnancy, the guidelines also support the recommendations to
commence with lower intensity activities, and potentially for short duration (15 minutes),
with progression towards regular exercise of moderate intensity (Zavorsky and Longo 2011,
Artal 2016, Hayman, Brown et al. 2016).

Many pregnant women face a number of barriers for regular exercise participation, including
symptoms, mobility, and misconceptions around benefits of exercise at moderate or high
intensity and exercise safety for commencing or continuing exercise during pregnancy
(Evenson and Bradley 2010, Cioffi, Schmied et al. 2010, Coll, Domingues et al. 2017).
Consequently, many pregnant women do not meet the minimum exercise recommendations
(Gjestland, Bø et al. 2013, Sui, Turnbull et al. 2013). Recent reviews on beliefs and behaviours
with respect to exercise during pregnancy have identified that regular exercise participation
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is reduced at the onset of pregnancy, and continues to decline as gestation progresses
(Poudevigne and O'Connor 2006, Evenson and Bradley 2010, Gaston and Cramp 2011).
Furthermore, the intensity, frequency and duration of any exercise undertaken have all been
found to decrease during pregnancy, compared to pre-pregnancy exercise behaviours, and
further reduce within the third trimester compared with the first trimester (Poudevigne and
O'Connor 2006, Gaston and Cramp 2011). Given the mismatch between the exercise that is
needed for pregnancy health, including for management of glycaemic control and
cardiometabolic changes, and the exercise behaviours and beliefs still held by many women
during pregnancy, there remains a clear need to identify practical exercise strategies that are
acceptable and non-threatening to pregnant women, and clinically effective in managing
pregnancy-related health changes, and of particular interest to the primary aim of this study,
glycaemic control.

2.2.1 Role of exercise in addressing maternal metabolic dysfunction
Exercise is one of the established essential therapies for the prevention and management of
type 2 diabetes (Boule, Haddad et al. 2001, Colberg 2017). Yet the utilisation of exercise as a
primary therapy for glycaemic control in pregnancy, including in GDM, remains limited. This
is largely due to a lack of conclusive evidence from studies done so far, where the varying
methods and different measures of glycaemic control used makes comparisons across the
literature challenging, and the effects of exercise training on glycaemic measures reported are
inconsistent and not strong enough to determine exercise dose needed for

glycaemic

improvement in pregnant women who are at-risk or diagnosed with GDM (Boule, Haddad et
al. 2001, Metzger, Buchanan et al. 2007, Ruchat and Mottola 2013, Colberg 2017). The
outcomes from prevention-focused studies indicate that higher levels of physical activity
during the pre-pregnancy period or within the first 20 weeks of pregnancy are more likely to
reduce GDM risk. Whereas, targeted exercise intervention studies aiming to improve the
prevention of gestational diabetes have not been conclusive (Dye, Knox et al. 1997, Dempsey,
Butler et al. 2004, Zhang, Solomon et al. 2006, Tobias, Zhang et al. 2011, Oostdam, Van Poppel
et al. 2012, Barakat, Pelaez et al. 2013, Yin, Li et al. 2014). Looking at the evidence for exercise
in managing GDM once women are diagnosed, there are a larger number of reviews on the
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role of exercise in GDM than the number of actual studies conducted to measure the effects of
exercise (acute bout or chronic training) . Overall, chronic exercise interventions have had
positive outcomes in GDM women, but with mixed and inconsistent results that relate to
differing measures of glycaemic control (Jovanovic-Peterson, Durak et al. 1989, Avery, Leon
et al. 1997, Brankston, Mitchell et al. 2003, Davenport, Mottola et al. 2008, de Barros, Lopes et
al. 2010). A recent systematic literature review of

GDM exercise intervention studies

concluded that regular moderate intensity exercise (aerobic or resistance-based), performed at
least three times per week, is both safe and effective for enhancing glycaemic control in
women with diagnosed gestational diabetes (Harrison, Shields et al. 2016).

Due to the limited studies currently available, there remains a large gap in understanding the
specific mechanisms of how exercise acutely affects glucose uptake and daily glycaemic
control in both normal pregnancy and those with GDM. To date, there has been considerable
reliance on the exercise effects that have been established in type 2 diabetes to inform exercise
approaches for management of metabolic dysfunction and diagnosed GDM. The underlying
physiology of peripheral insulin resistance is similar across pregnancy, GDM and type 2
diabetes; however, the insulin resistance in pregnancy is a normal and necessary physiological
process, as opposed to the abnormal pathophysiology seen in type 2 diabetes. Further, the
causes of beta-cell dysfunction in GDM are not yet well defined or understood (Bung and
Artal 1996, Buchanan and Xiang 2005, Demirci, Ernst et al. 2012). Therefore, the role and effect
of exercise in pregnancy, and in GDM, on peripheral insulin resistance and glycaemic
responses may not be the same as established in type 2 diabetes. On the other hand, skeletal
muscle is the primary site for the peripheral insulin resistance that occurs in pregnancy and in
type 2 diabetes (Leturque, Burnol et al. 1984, Barbour, McCurdy et al. 2007). This is significant
because of the two primary treatments currently utilised in pregnancy to manage glycaemic
control, being specialised dietary intervention and insulin therapy, neither act directly on the
skeletal muscle site. Physiologically, the use of exercise as a stimulus acting on skeletal muscle
to augment glucose uptake should be an effective component for glycaemic control in
pregnancy. Currently, the required dose and key variables to optimise exercise effect in
pregnancy glycaemic control are not known.
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Early studies reporting on the acute effects of a single bout of exercise in pregnant women
were all performed using a continuous structure, with most using a cycle ergometer as the
mode (Guzman and Caplan 1970, Sady, Carpenter et al. 1989, Artal, Masaki et al. 1990, Bonen,
Campagna et al. 1992, Jaque-Fortunato, Wiswell et al. 1996, Lesser, Gruppuso et al. 1996,
Avery and Walker 2001).

A number of these studies reported on cardiovascular and

metabolic gas exchange responses during and post-exercise, in addition to acute glycaemic
changes; with a few also measuring sympathetic control and substrate utilisation. These are
physiological factors that can have secondary effects on glycaemic levels and are known to be
different at rest between pregnant and non-pregnant women. Therefore, the present study
included measures of heart rate variability and metabolic gas exchange, in addition to
glycaemic responses, to be able to provide a more comprehensive picture of the effects of
discontinuous exercise compared to continuous exercise in pregnant women. The exercise
mode of cycling was chosen, as it allowed for more appropriate comparison to the early
pregnancy literature and provided an accurate method for controlling the total work
(representative of metabolic cost, and energy expenditure) performed in each protocol such
that it could be equally matched.

2.3

Exercise - a potent stimulus for glycaemic control

In non-pregnant study populations, exercise is a well-established treatment for reducing
hyperglycaemic blood levels and improving daily glycaemic control in persons at-risk of or
diagnosed with metabolic dysfunction (Boulé, Weisnagel et al. 2005, Praet, Manders et al.
2006, Praet and van Loon 2007, Colberg, Sigal et al. 2010, van Dijk, Tummers et al. 2012,
MacLeod, Terada et al. 2013, Ruchat and Mottola 2013, Qiu, Cai et al. 2014). Previous
investigations have demonstrated that the glucose regulatory effects of exercise take place at
the skeletal muscle, the primary tissue affected by chronic peripheral insulin resistance
(Devlin and Horton 1985, Goodyear and Kahn 1998). As an acute stimulus, exercise facilitates
enhanced glucose uptake at skeletal muscle by mechanisms that are both insulin-mediated
and independent of insulin via muscle contraction (Burstein, Epstein et al. 1990, Wright,
Hucker et al. 2004, Hawley and Lessard 2008). Specifically, a single bout of exercise augments
glycaemic control through several mechanisms, including: enhanced glucose uptake in
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skeletal muscle via increased GLUT4 translocation and GLUT4 mRNA expression; increase
activity of skeletal muscle AMP-activated protein kinase (AMPK); regulation of other proteins
involved in insulin signalling pathways; increasing the oxidative capacity of skeletal muscle;
and acute muscle glycogen depletion (Houmard, Hickey et al. 1995, Kennedy, Hirshman et al.
1999, Kuo, Browning et al. 1999, Chen, Stephens et al. 2003, Kraniou, Cameron-Smith et al.
2006, Sriwijitkamol, Coletta et al. 2007, O'Neill 2013). In pregnancy, however, the peripheral
insulin resistance is not a pathophysiological process of metabolic dysfunction, but rather a
naturally occurring biological mechanism that ensures adequate blood glucose supply is
available to the developing foetus (Buchanan 1994, Sorenson and Brelje 1997). Therefore, it is
not yet known if the acute mechanisms of glucose uptake at skeletal muscle, or the degree of
augmentation will be the same in pregnancy, as the underlying cause is protective, compared
to maladaptive in non-pregnant populations. Based on this, there is a gap in studies looking at
both physiological mechanisms and clinical effects of acute exercise on glycaemic responses in
pregnancy.

2.3.1 What dose of exercise is needed?
The metabolic response of the body to exercise is influenced by many factors, including the
intensity, volume, duration, energy expenditure (total work) o, mode (weight-bearing or nonweight bearing; aerobic endurance or strength training under resistance load), carbohydrate
consumption, and presence of chronic insulin resistance and abnormal glucose tolerance
(Devlin et al., 1987). Acute and chronic exercise investigations that have compared the
differential effects of exercise load-variables and modalities have produced a range of
significant findings showing positive effects on acute blood glucose and insulin sensitivity,
and longer-term glycaemic control. (Devlin, Hirshman et al. 1987, Chen, Stephens et al. 2003,
Hansen, Dendale et al. 2009, Manders, Van Dijk et al. 2010, Roberts, Little et al. 2013, Krause,
Rodrigues-Krause et al. 2014, Grace, Chan et al. 2017). Both exercise intensity and total energy
expenditure have been described as key exercise variables for improving glycaemic control
during exercise (Larsen, Dela et al. 1999, Grace, Chan et al. 2017). One area of rapidly growing
research that has focused on manipulating these two variables is interval-based exercise. One
advantage of this exercise structure is that by utilising short bouts of exercise with intermittent
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rest (or active rest), participants can undertake exercise at higher intensities than they would
likely be able to perform during continuous exercise. Depending on the protocol design, other
practical benefits include reduced total volume of training and reduced training time, and
depending on the population, with comparable or greater cardiometabolic training gains
(Bartlett, Hwa Joo et al. 2012, Karstoft, Winding et al. 2014, Larsen, Welde et al. 2014,
Mitranun, Deerochanawong et al. 2014).

2.3.2 Continuous or interval training for glycaemic control?
High intensity exercise/interval training (HIIT) has been the focus of much research in recent
years, because of its potential for superior effects on cardiovascular and metabolic responses,
and practical benefits for reducing other exercise variables, such as volume and duration. In
healthy people, studies of HIIT, sprint interval training (SIT) and moderate intensity
continuous training have produced comparable increases in the oxidative potential of skeletal
muscle; a factor associated with insulin sensitivity (Gibala, Little et al. 2006, Burgomaster,
Howarth et al. 2008, Hood, Little et al. 2011, Bartlett, Hwa Joo et al. 2012). In people with
metabolic dysfunction, such as obesity and type 2 diabetes, evidence from HIIT and SIT
studies has shown greater effects on glycaemic measures, including acute post-exercise blood
glucose reduction, enhanced insulin signalling in skeletal muscle, and blunting post-prandial
blood glucose levels over 24 hours, compared to traditional continuous training at moderate
intensity (Tjonna, Lee et al. 2008, Karstoft, Winding et al. 2014, Mitranun, Deerochanawong et
al. 2014). Thus, there is a growing volume of literature for the effectiveness of high intensity
interval exercise. However, studies investigating changes in glycaemic responses to interval
exercise when performed at intensities lower than high or supramaximal are scarce.

Interval training has only recently been explored in any context in pregnancy (Halse, Wallman
et al. 2014, Ong, Wallman et al. 2016); however, there have been no investigations of the effects
of an acute bout of interval structured exercise, compared with continuous exercise, on acute
and 24-hour glycaemic responses in pregnant women. One study added 6 short bouts of selfpaced higher intensity pedalling into a continuous cycling protocol, however the energy
expenditure, as a product of total work, differed between the groups, and the protocol was not

page 28

distinct from a continuous protocol, to objectively compare effects on glucose responses (Ong,
Wallman et al. 2016). While recent updates to the pregnancy guidelines now clearly advocate
for moderate intensity exercise as the minimum standard, they also continue to recommend
that pregnant women not currently exercising and/or who were inactive prior to pregnancy
should commence exercise at a lower intensity level and for shorter duration (Hayman, Brown
et al. 2016). This would mean that utilising a high intensity interval protocol at this stage
would not align with available evidence or current pregnancy guidelines for women who are
inactive. Based on this, and because the development of this study protocol and
commencement of data collection began several years prior to the current guidelines being
released, the present study has focused on a comparison of discontinuous exercise performed
at moderate intensity with continuous exercise performed at low intensity.
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CHAPTER THREE:
METHODS
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3.

METHODS

This study was approved by the University of Wollongong/Illawarra Shoalhaven Local Health
District Health and Medical Human Research Ethics Committee (HE14/050, Appendix 1), with
authorisation also approved by Illawarra Shoalhaven Local Health District Health Research
Directorate (Appendix 2).

3.1

Participants

Pregnant and non-pregnant female volunteers were recruited for the investigation, with nonpregnant participants included to serve as a control group to identify whether potential
changes in glycaemic and cardiometabolic responses to the different exercise protocols were
also specific to pregnancy condition. All participants were aged between 18–40 years, nonsmokers, and had no physical contraindications for exercise. Additional inclusion criteria for
all pregnant participants were that they were in the second trimester (14—28 weeks)
pregnancy, had completed at least the first antenatal consultation, confirmation of a singleton
pregnancy, and absence of other associated risk factors for pre-term delivery (such as placenta
previa, known high risk pregnancy or risk of uterus rupture). Additionally, participants with
a fasting blood glucose level >5.1 mmol.L-1 (classification threshold for gestational diabetes1)
and early diagnosis of GDM in the pregnancy were included in the investigation. This is
because the original study design involved three separate groups, being pregnant women,
women with GDM and non-pregnant, healthy women (control). A combination to combine
the GDM and the pregnancy women into one group and re-focus the study on pregnant
women was due to significant recruitment challenges, and the raw blood glucose data

1

The Illawarra region of New South Wales (where the study was conducted) follows the Australian Diabetes in
Pregnancy Society (ADIPS) guidelines for GDM testing and diagnosis, which includes an additional screening and
diagnostic protocol for women identified as ‘at-risk’ for GDM conducted earlier than the traditional 24-28 weeks
GDM screening. This is often in the first antenatal visit (Moses, Morris et al. 2011, Nankervis, McIntyre et al. 2013).
Diagnosis is based on the threshold criteria recommended by the International Association of Diabetes and
Pregnancy Study Groups (IADPSG) from the results of the Hyperglycaemia and Adverse Pregnancy Outcome
study (HAPO Study Cooperative Research Group 2008, International Association of Diabetes and Pregnancy Study
Groups Consensus Panel 2010).
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showing that all GDM women had baseline glycaemic responses within the clinically normal
threshold for pregnancy (beyond their initial diagnostic level).

For non-pregnant participants, they were only controlled to match the age, non-smoking and
no contraindications criteria. Other characteristics (previous pregnancy, phase of menstrual
cycle, BMI, physical activity level) were not controlled, due to the pilot nature of this study.

3.1.1 Exercise Screening
Participants all completed a Physical Activity Readiness Questionnaire for Everyone,
(PARQ+, Appendix 3), (Warburton, Gledhill et al. 2011). Pregnant participants underwent
additional screening using the Physical Activity Readiness Medical Evaluation for
Pregnancy (PARmed-X, Appendix 4), (Wolfe and Mottola, 2003). The PARmed-X was
reviewed and signed by a medical practitioner or mid-wife. Screening processes were able to
be completed during the first trimester for pregnant participants.

3.2
3.2.1

Experimental Procedures
Study Design

The study used a non-randomised design to compare individual responses over a 48-hour
period (24-hours before exercise and 24-hours following exercise) to two different acute
exercise protocols completed in consecutive phases (Figure 3.1). Participants first underwent a
baseline submaximal exercise test (Phase 1), from which their individual workload (Watts)
was calculated. This workload (watts) was then used for the Continuous exercise protocol
(Phase 2). For the Discontinuous exercise protocol in Phase 3, the workload for exercise
periods from Phase 2 was doubled and the actual exercise time was halved. While not ideal,
the order of the exercise protocols was the same for all participants. The consecutive, nonrandomised order was decided on to ensure that pregnant participants who were potentially
inactive (during and/or prior to pregnancy), self-reported as ‘unfit’ and/or inexperienced with
semi-recumbent cycling position, would first be able to complete the continuous protocol.
This also ensured that the workload completed in the Continuous protocol directly informed
the workload for the discontinuous protocol, meaning that total work (energy expenditure)
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for each protocol was more accurately matched. The phases were completed over a minimum
of three weeks and a maximum of six weeks, to limit the effects of physiological changes
associated with progression of a normal pregnancy, in particular changes in hormone levels
known to impact insulin sensitivity later in the second trimester (Catalano, Tyzbir et al. 1991,
Catalano, Tyzbir et al. 1993, Sorenson and Brelje 1997). Between each phase, a minimum
‘washout’ period of 5 days was maintained. This was to ensure no carry-over of acute
glycaemic effects from the previous exercise trial,

no short-term training effects were

observed from performing three repeated bouts of exercise in a short timeframe, and for
practical consideration for participants who were required to adhere to standardisation
elements for each phase, which included no purposeful exercise (other than the study
protocol) for 24-hours prior to, and over the duration of each phase.

3.2.2

Acute exercise bout

A modified cycle ergometer (Lode BV Medical Technology; Excalibur Sport model; The
Netherlands) was used to conduct the exercise protocols in each phase. Based on consultation
with the University’s engineering department, the seat set-up for the ergometer was altered
specifically for this study to be able to provide a broader saddle with back support in a semireclined seated posture (Figure 3.2 A and B). Semi-recumbent posture during cycling exercise
in pregnant women has been shown to be safe and comparable to an upright (traditional)
cycling posture, with similar maternal metabolic responses, including maternal and foetal
heart rate responses (O'Neill, Cooper et al. 2006). The seat position, seat height and length to
the pedals were modifiable and adjusted to suit each individual. These positions were
recorded during Phase 1 to ensure replication for the subsequent trial phases. The Lode
Excalibur model of cycle ergometer used enables workload (Watts) to be set and maintained,
regardless of changes in individual pedal cadence. This allowed the workload for Phase 2 and
Phase 3 to be set based on pre-determined watts, and not dependent on cadence. This
addressed practical considerations for pregnant women at different stages of gestation
comfort, size, and different experience levels with cycling exercise by removing the need for
constant cadence.
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Low and moderate aerobic exercise intensities have been utilised safely in healthy pregnant
women, as well as among pregnant women with cardiovascular risk factors (obesity, physical
inactivity), who have not exercised prior to or during pregnancy, and who have GDM or overt
diabetes (Lesser, Gruppuso et al. 1996, Avery and Walker 2001, Coquart, Lemaire et al. 2008,
Davenport, Charlesworth et al. 2008, Ong, Guelfi et al. 2009, Halse, Wallman et al. 2013). This
component of the study design was determined (and implemented through commencement of
data collection) prior to the current Australian guidelines release in 2016, where moderate
intensity is recommended for all women (Hayman, Brown et al. 2016).

Figure 3.1 Study design
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A

B

Figure

3.2:

A)

Participant

set-up

on

the

modified

Lode

ergometer

B) Close up of modified seat-base, with rail and hydraulic system to permit changes to
seat height, angle and length adjustment.
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3.2.3 Study Protocol

3.2.3.1 Phase 1 – Study familiarisation and establishing individual workload
Phase 1 involved two components: (i) familiarisation with the laboratory, equipment and
study protocol; (ii) a baseline exercise test. The components were completed either within the
same session, or across two days, as chosen by each participant. Familiarisation involved
demonstration of the continuous glucose monitoring device (CGM - Medtronic iPro2,
MiniMed Inc. USA, depicted in Figure 3.3 A and B), and practice of self-testing BGL using the
glucometer, or blood glucose monitor (ACCU-CHECK Performa, Roche Diagnostics 2013,
depicted in Figure 3.3 C); trial of the oral-nasal respiratory face mask for correct size and fit;
and detailed overview for exercise protocols and standardisation requirements for each phase,
with further opportunity for questions. Participants were given a study diary to be used to
record the timing and details of meals (including drinks), data for self-measured calibration
BGL, medications, incidental physical activity, plus occurrence of other relevant events (i.e.
stressful or emotional events, or an unusually physically intensive work day). Timing and
values for calibration BGLs, meals, physical activity and medications were required for entry
into the CGM database (Medtronic CareLink program) in order to accurately correlate glucose
readings from the CGM device. Study diaries were also a back-up in the event of any
significant anomalies in BGL data, to provide potential insight and identification of a reason
for unexpected blood glucose responses.

Each participant was taken through the protocol for standardising meals to be the same for
each day (24-hour period) in both phases. Participants developed their own individualised
single-day meal plan (including accounting for drinks with caloric value) that they followed
for each 24-hour period of the study in Phases 2 and 3. Those already following a prescribed
dietary plan (e.g. GDM women) continued to use this for their study meal plan. Participants
were encouraged to eat at the same or similar times wherever possible. This method for
individual diet standardisation was designed in consultation with a dietitian experienced in
pregnancy and gestational diabetes care, and has been previously used in healthy adults, type
2 diabetes and pregnant populations (Gibala, Little et al. 2006, Burgomaster, Howarth et al.
2008, Mikus, Oberlin et al. 2012, Halse, Wallman et al. 2013).
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Baseline physical activity levels were identified during the familiarisation session. Questions
were asked of each participant to determine current involvement in physical activity and
exercise (covering type, regularity and volume per week, and estimated intensity based on
qualitative description of exertion) in order to match against current Australian Physical
Activity Guidelines. Pregnant participants were also asked about pre-pregnancy physical
activity (over the preceding 12 months). The International Physical Activity Questionnaire
was completed to identify a baseline of their normal weekly incidental activity (Craig,
Marshall et al. 2003). Participants were encouraged to maintain similar incidental physical
activity levels (e.g. walking with a pram between places or work-related tasks) during the
study and were instructed to avoid any prolonged physical activity and not undertake
additional exercise during the study phases. Walking or physical activity of 10 minutes
duration or longer were recorded in the study diary. IPAQ responses were used to identify
any substantial differences between Phases 2 and 3 in physical activity during the week prior
to each phase. The commencement time of the exercise protocols was kept consistent across
the phases for each individual to reduce potential BGL variation in relation to normal
incidental activity, or meal times (pre-prandial or post-prandial exercise).

The baseline exercise test involved participants completing a sub-maximal cycle test on a
modified Lode ergometer. Participants were set-up on the cycle ergometer for collection of
metabolic expired gas (TrueOne® 2400, Parvo Medics, Utah USA), heart rate (Polar RS800CX
monitor, paired with the Polar WearLink + transmitter W.I.ND sensor and strap - Polar
Electro Oy, Finland), rating of perceived exertion (Borg 1982), capillary BGL via blood glucose
monitor, and manual systolic and diastolic blood pressure (sphygmomanometer by Prestige
Medical; stethoscope 3MTM Littman Classic II SE). Participants were rested for a 5-minute
period seated on the ergometer before commencing a 2-minute warm-up at a low load (0-20
Watts). The test included three stages of 3-minute steady-stage cycling, with workload
incrementally increased for each stage. Upon completion of the work periods, a 3-minute cooldown was performed at the same workload as the warm-up stage. Participants then rested for
a 5-minute period on the ergometer.
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Metabolic gas analysis was collected throughout the exercise protocol via using a two-way
breathing, oral-nasal facemask (Face Mask Series 7910; Hans Rudolph Inc. USA), shown in
Figure 3.2.2A. Heart rate (beats per minute, variability) were measured continuously, and
blood pressure and perceived effort were measured in the third minute of each stage.
Following the cooldown and rest period, participants remained seated on the ergometer and

.

attached to the metabolic cart. Predictive calculations of VO2peak using GraphPad Prism (Prism
6 for Windows, Version 6.07, June 2015, GraphPad Software, Inc.) were conducted:
Equation1: Linear regression of Watts (X) and HR (Y), using aged-predicted maximum
heart rate (HRmax = 220bpm – [age]) = prediction of peak exercise Watts. Equation 2: Based

.

on predicted peak Watts (equation 1), linear regression of Watts (X) and VO2 (L.min-1)

.

response of each stage = predictedVO2peak.

.

.

From the predicted VO2peak, the individual’s 25%VO2peak was calculated as the targeted oxygen

.

consumption rate VO2 (L.min-1) for the Continuous exercise protocol in Phase 2. To determine
the Watts (workload) for the Continuous protocol, participants completed a short,5-minute
cycling trial to identify the workload on the ergometer with the targeted oxygen consumption

.

rate VO2 (L.min-1) on the metabolic cart.

3.2.3.2 Phases 2 and 3: Continuous and Discontinuous exercise protocols
Participants followed the same protocol over a 48-hour period, therefore Day 1 and Day 2 as
described here were the same for Phase 2 and Phase 3. Participants attended the laboratory at
the University of Wollongong (UOW) at their chosen start time of Day 1, which became their
starting time for Day 1 and Day 2 (exercise trial) across both phases. Blood glucose was
collected throughout the entire 48-hour period for each phase via CGM.

Day 1 (Control) – no exercise
Day 1 (24-hours) served as the control period with no exercise stimulus. Participants attended
the laboratory. The IPAQ was completed, and the investigator also discussed any health
changes since the previous session. The specific exercise protocol requirements were revised.
A disposable sensor (EnliteTM Glucose Sensor MMT-700A) was inserted subcutaneously at the
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upper gluteal site via the compatible insertion device (EnliteTM Serter, Medtronic MiniMed Inc.
USA), as per the manufacturer’s instructions. An example of the insertion site and the monitor
in-situ on a participant is shown in Figure 3.3. This site was chosen to avoid any psychological
aversion or barrier that pregnant participants may have had towards insertion at the
abdominal site. The time of insertion was recorded.

Participants were required to take their BGL at 1-hour and 2-hour after the CGM was attached
to activate and calibrate the device, as per the manufacturer’s instructions. The specific time
points were recorded in Study Diary and added as mobile phone reminders, for reference.
A baseline BGL was measured and recorded manually by the investigator (capillary fingerprick testing with each participant’s allocated study glucometer). Participants were given a
standardised snack - a small muesli bar (Carman’s Classic Fruit & Nut Muesli Bar – Bite Size,
Carman’s Fine Foods, Victoria Australia; bite-sized portions purchased from Costco; but now
discontinued at time of writing) containing 13 grams of carbohydrate (a single carbohydrate
serve = 15 grams). Post-prandial BGL responses to the snack were manually measured at 5, 10,
15 and 30 minutes. The muesli bar was the only meal standardised across all participants in
the study. With all other dietary components individualised to each participant, the inclusion
of a standardised meal provided a valid method to evaluate acute post-prandial responses to
different conditions, being exercise on Day 2 versus no exercise on Day 1; and Continuous
exercise in Phase 2 versus Discontinuous exercise in Phase 3. Following the laboratory session,
participants continued to follow their meal plan and record details of meals, regular BGL
measures, medication and physical activity in the study diary.

Day 2 (Intervention) - acute exercise bout
Day 2 (second 24-hours) served as the intervention day for Phase 2 and Phase 3. Participants
attended the laboratory session at the same time as the previous day. The investigator asked
about their general health on that day and reviewed the study diary to determine any
difficulties or concerns with their monitored BGL and to ensure they were appropriate to
continue with the exercise trial. The heart rate monitor was fitted, and participants were
seated for 10 minutes, after which resting blood pressure, heart rate and baseline (pre-
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exercise) BGL were measured. Participants were encouraged to have a drink of water prior to
being set up on the ergometer.

Participants were seated on the ergometer, set up with oral-nasal facemask attached to the
calibrated metabolic cart system and given time to ensure their set-up was comfortable. This
time was also used to revise the specific exercise protocol procedures for the session. At the
commencement of the trial, the starting time for the heart rate monitor, metabolic cart system
and a separate stopwatch were all synced. Resting measures were then collected for 5 minutes
while the participant was seated and stationary on the cycle ergometer, followed by a 2minute warm-up on the ergometer with no load (0 Watts).
-

Continuous exercise (Phase 2): 30-minutes continuous cycling at a load (watts) equivalent

.

to low intensity, based on individual 25% predicted VO2peak, calculated in Phase 1.
-

Discontinuous exercise (Phase 3): total of 30-minutes discontinuous cycling, structured as
6 rounds of exercise and rest intervals, with equal interval duration of 2:30 minutes.
This equated to 15 minutes of total exercise over the 30-minute protocol. Exercise
intervals were performed at twice the Wattage used in Phase 2, aiming for

.

approximately ~ 50%VO2peak prediction.

Heart rate was measured continuously throughout exercise via Polar RS800CX monitor (Polar
Electro Oy, Finland), and manually recorded for participant monitoring every minute. Blood
pressure was monitored every 5 minutes during the Continuous Protocol, and during the final
minute of each interval of the Discontinuous Protocol. Similarly, RPE was recorded at the end
of every 5 minutes of exercise during the Continuous Protocol and during the final 30 seconds
of each work interval in the Discontinuous Protocol. Capillary BGL was manually measured
by the investigator in the middle of each exercise protocol (at 12 ½ minutes, which fell during
the third (of six) work intervals of the Discontinuous Protocol). Manual BGL was also
measured immediately after the cessation of the 30-minute exercise period. After the exercise
bout, participants remained seated for a 10-minute recovery period. The muesli bar snack was
provided 15 minutes post-exercise, with BGLs collected at 5, 10, 15, 20, 25, 30- and 45-minutes.
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On Day 3, at the completion of the 48 hours, the investigator removed the CGM device, and
the completed study diary was collected from the participant.

3.3

Experimental Measurements

3.3.1 Blood glucose
Blood glucose was collected throughout the entire 48-hour period for Phase 2 and Phase 3 via
continuous glucose monitoring (CGM), as well as manually via glucometer prior to, during
and for 30-minutes post-exercise. The use of CGM for measuring the effects of exercise
interventions has been well demonstrated in type 2 diabetes, pregnancy and GDM studies,
with no reported adverse events (Praet, Manders et al. 2006, Kestilä, Ekblad et al. 2007,
McLachlan, Jenkins et al. 2007, Manders, Van Dijk et al. 2010, Dmitrovic, Katcher et al. 2011,
Gillen, Little et al. 2012, Van Dijk, Manders et al. 2013). The iPro2 CGM device measures
interstitial glucose by sampling every 5 minutes. It has a blinded interface, with BGL
measured only provided retrospectively once data is downloaded to CareLink iPro Software
online system. To calibrate the CGM device, participants were required to take a minimum of
four manual BGL readings each day, including fasting and before bed to ensure the device’s
calibration requirements were met. Participants with their own glucometer device (GDM
women) continued to use their device. All other participants were provided with a glucometer
device, disposable single-use lancets (ACCU-CHECK Safe-T-Pro Plus), testing strips (ACCUCHEK Performa Test Strips), and a small disposable sharps container for used lancets and
strips, shown in Figure 3.3. To reduce equipment or procedural differences on the reliability of
BGL data, participants were fitted with the same CGM device and were given the same
glucometer throughout the period of the investigation. The location and side of the body of
CGM sensor insertion was recorded and then replicated for each phase. Participants were
required to conduct their own BGL testing several times each day, so the method for fingerprick capillary testing was standardised, with the participants trained by the instructor to
adopt an identical technique.
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At the end of Day 3, the CGM device was removed and data were downloaded to Care Link
iPro Software online system. Each woman was given a code to de-identify the data entry into
the program. Details from the study diary were manually entered for calibration. The CGM
device was cleaned thoroughly between each use, as per manufacturer’s instructions. The
CareLink program settings for target blood glucose range were modified for the purpose of
the study, with the high threshold set to 7.5 mmol.L-1 to align with the peak 1-hr post–prandial
BGL target for pregnancy (Nankervis, McIntyre et al. 2013). The low threshold was kept at
3.9mmol.L-1 as per the original settings of the device.

A

B

C

Figure 3.3: A) Continuous Glucose Monitor (CGM) sensor and device inserted at the upper
gluteal subcutaneous site, B) CGM device covered by water-proof dressing to further secure
position of device, C) Self-monitoring blood glucose equipment – disposable lancets, strips
and glucometer.
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3.3.1.1 Glycaemic control over 24-hours
Daily blood glucose control measures were calculated using the CGM data, and compared
Day 1 (control day) and Day 2 (intervention day) for the following glycaemic measures
(Rodbard 2012, Monnier, Colette et al. 2017):
-

Mean BGL (mmol.L-1) for the entire 24hr period; and the 8hrs overnight (10pm-6am)

-

Standard deviation (standard deviation of BGL around the 24-hr mean BGL) (mmol.L1

-

); also calculated for 8hrs overnight (10pm-6am)

Coefficient of variation (%) of all BGL for the entire 24hr period (determined by [SD of
glucose]/[mean glucose]

-

Minimum BGL (mmol.L-1) recorded overnight (between 10pm-6am)

Fasting and post-prandial BGL responses during each 24-hour period were also compared:
-

Fasting BGL (mmol.L-1), presented as mean BGL (mmol.L-1) over the 60 minutes prior
to first meal or drink consumed; and peak BGL (mmol.L-1) during 60 minutes prior to
first meal or drink consumed

-

Post-prandial (1-hour) BGL – the meal chosen for comparative measures of prolonged
exercise effect on post-prandial BGL was selected as the main meal (breakfast, lunch,
or dinner) that would correspond to 10–16 hours after exercise.

Post-prandial

measures are presented as i) mean BGL (mmol.L-1) of three consecutive sample
readings (representing a 15-minute window) identified at the 1-hour mark; and ii)
peak post-prandial BGL within the first 60 minutes after eating.

3.3.1.2 Acute glycaemic responses post-exercise
As the CGM device had a blinded interface, BGL were also monitored manually by the
investigator using the glucometer to allow appropriate management of participant BGL
before, during and in recovery after exercise.
Using manual measures taken, baseline pre-exercise BGL was then compared to: i) immediate
post-exercise BGL (mmol.L-1) at the end of the exercise protocol; and ii) 15 minutes postexercise BGL (mmol.L-1).
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The post-prandial BGL (1-hour after standardised snack) were analysed and compared using
the CGM data. The use of 1-hour post-prandial is common as a clinical marker for glycaemic
control in diabetes (Nankervis, McIntyre et al. 2013, Inzucchi, Bergenstal et al. 2015). Peak
blood glucose level during the 60-minute postprandial timeframe was also compared between
Day 1 and Day 2, as peak BGL was not expected to occur at the 1-hour post-prandial time
point. Post-prandial BGL responses to the standardised snack were also manually measured
by the investigator for 30 minutes (at 5, 10, 15 and 30 minutes), to be able to match the exact
time points of the BGL’s obtained from the CGM data. Manual monitoring was kept to 30
minutes to reduce the total time required for participants to be in the laboratory.

3.3.2 Gas exchange

.

Measures of oxygen consumption (VO2 L.min-1), respiratory exchange ratio (RER), and minute

.

ventilation (VE L.min-1) were collected by TrueOne® 2400 metabolic cart. The system was
calibrated before each use, following the manufacturer’s procedures using Alpha standard
gas, and standardised volume syringe. Measurements were recorded every 15 seconds during
pre-exercise baseline (5 minutes), exercise (30 minutes) and recovery (10 minutes) for each

.

protocol. Raw data was downloaded to an excel file, where mean values for VO2 L.min-1, RER

.

and VE during resting, exercising and recovery stages were calculated for each participant.
3.3.3 Cardiac frequency, heart rate variability and blood pressure
Heart rate was recorded via the Polar RS800CX monitor. Electrode cream was used to wet the
electrode area of the strap to enhance conductivity during cycling. For each protocol, heart
rate was continuously recorded during the rest (5 minutes), warm-up (2 minutes), exercise
protocol (30 minutes) and recovery (10 minutes) stages.

Mean heart rate was measured for the following periods:
i.

The 5-minute pre-exercise period: seated on ergometer attached to metabolic cart

ii.

The entire 30-minute exercise protocol for each exercise intervention

iii.

The 10-minute recovery period post-exercise intervention: participants remained
seated on ergometer (with expired gas exchange collection also continuing).
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Heart rate data was transferred from the Polar RS800CX via infrared Polar IRDA USB
Adaptor Driver to a computer using Polar ProTrainer 5 software. Raw data was exported
from Pro-Trainer into the Kubios HRV Analysis program for analysis (Version 2.2, May 2014;
(Tarvainen, Niskanen et al. 2014)). Spectral analysis details include:

−

Points in frequency-domain: 256 points/Hz

−

FFT spectrum options: Window width 256 s, Window overlap 50 %

−

AR spectrum options: AR model order 16, Use factorisation No

Heart rate variability data was collected and analysed from short-term (5-minute) recordings,
and followed the European Society for Cardiology guidelines (Cardiology, Pacing et al. 1996).
Within the Kubios analysis program, artefact correction was done to ‘very low’ or ‘low’ level
correction only when there was a clearly identifiable signal disruption or occasional ectopic
beat. This correction level was chosen as it was observed to remove outliers without overcorrection of the rhythm. For an individual participant, the same correction level was used
consistently for all of their analyses. Measures of HRV were collected in both the Time (Pnn50,
SDNN, RMSSD, mean HR, mean RR) and Frequency (Peak Hz– Very Low Frequency VLF,
Low Frequency LF, High Frequency LF; Absolute ms2 – VLF, LF, HF, Total Power; Relative %
- VLF, LF, HF; LF/HF ratio) domains. Frequency domain measures for absolute and peak
spectral power were log transformed using a normal distribution and reported as normalised
units (n.u.), based on the process recommended by European Society for Cardiology
guidelines (Cardiology, Pacing et al. 1996).

The short-term (ST, 5-minute) sample recordings for both Time and Frequency measures were
selected at a standardised time from the full HRV dataset of each protocol (resting, exercise,
recovery period), as outlined below. If small adjustments in exact timing were required (based
on signal disruption), the adjusted time was standardised across protocols for that participant:

−

Resting: HR was recorded for 20 minutes in a stationary, semi-reclined position in a
darkened and quiet room. The 5-minute sample was selected between minute-10 and
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minute-15, or in the event of too much artefact, the nearest 5-minute period of
continuous clean sampling.

−

Exercise: This was a non-stationary sample. For the Continuous protocol, the 5-minute
sample was selected between minute-15 and minute-20 during exercise. For the
Discontinuous protocol, the 5-minute sample required 2 x 2½ minute consecutive
exercise intervals to be combined using the Kubios software. This was done using
either the 3rd and 4th exercise intervals, or 4th and 5th exercise intervals, based on the
cleanest sample.

−

Recovery: The 5-minute sample was selected from minute-3 until minute-7 of the 10minute post-exercise recovery, which was in a stationary, seated position on the bike.

3.3.4 Psychophysical measures

3.3.4.1 Rating of perceived exertion
Rating of perceived exertion was measured via the Borg scale (Borg 1982), with participants
providing a score from 6 (no exertion at all, or very, very light) to 20 (maximal exertion, or
very, very hard). Participants were asked to first rate how hard the exercise felt for their whole
body. They were then separately asked how to rate how hard the exercise felt specifically for
their legs. This second rating was included based on the consideration that cycling is an
isolated movement for the lower limbs, and for people not experienced with regular physical
activity or the mode of cycling, their perception score of overall exertion might reflect
localised leg muscular fatigue rather than whole body effort.

3.3.4.2 Qualitative perception of exercise difficulty and enjoyment
Adequate exercise participation for health benefit during pregnancy faces several perceptual
and practical barriers for women (Duncombe, Wertheim et al. 2009, Evenson and Bradley
2010). Therefore, consideration is needed of not only whether a particular type of exercise is
effective, but also whether it is acceptable and likely to be undertaken by pregnant women.

page 46

Two questions were asked at the completion of their study (end of Phase 3):
i)

Reflecting on the experience of completing the two difference exercise trials, which
of the 30 minutes did you find more difficult? Would you say ‘x’ protocol [the
protocol identified as more difficult] was mildly, moderately or a lot more
difficult? Were there any factors that you found made it more difficult?

ii)

Reflecting on the experience of completing the two difference exercise trials, which
type of exercise did you find that you enjoyed more or would be more likely to
choose to do as exercise? Was there any reason that you found ‘x’ protocol [the
protocol identified as more enjoyable] more enjoyable?

3.4

Data analysis

A repeated measures two-way ANOVA, with post-hoc Tukey was performed to analyse the
interactions between participant group and exercise protocol, and participant group and time
(comparing pre-exercise 24hours to post-exercise 24-hours). For blood glucose changes postexercise, metabolic gas exchange and HRV measures, the Time condition refers to pre-exercise
(baseline), exercising and/or recovery periods. For 24-hour blood glucose measures (24 hour
mean, standard deviation, coefficient of variation, fasting BGL, and post-prandial BGL), the
Time condition refers to comparing Day 1 (no exercise) and Day 2 (after exercise).

A one-way ANOVA with Bonferroni pairwise comparisons were performed for pregnant
women and non-pregnant women separately, to compare the specific effects of each protocol
on acute blood glucose changes over time (pre-exercise, immediate post, 15 minutes post)
following a single bout of exercise.

When the data for both groups was pooled to evaluate the effect of the protocol type (and
removing pregnancy as a variable), a paired two-tailed t-test was used to analyse main effects.

Alpha was set at 0.05 for all analyses. All data has been reported as mean with 95% confidence
intervals (CI), unless otherwise described as mean with standard deviation (SD).
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CHAPTER FOUR:
RESULTS
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4.
4.1

RESULTS

Participants

4.1.1 Participant characteristics
Fourteen women completed all requirements of the study, with an equal number in the nonpregnant (n=7) and pregnant (n=7) groups. The baseline characteristics of the two groups are
presented in Table 4.1. Mean age was not different between pregnant women and nonpregnant women. Mean BMI was also not significantly different. Four out of the seven
pregnant women had been diagnosed with GDM early in their pregnancy, based on fasting
levels > 5. 1mmo.l-1.

Table 4.1 Participant baseline characteristics
NON-PREGNANT

PREGNANT

Healthy

GDM

30.6 + 6.6

31.9 + 1.1

31.6

32

(22 - 39)

(30 - 37)

(31—37)

(30—33)

Gestation (week)

N/A

14 - 25

18—22

14—25

BMI (kg.m-2)

24.6 + 2.7

26.1 + 6.3

31

22.5

(18.9 - 27.3)

(20.9 - 37.5)

(22.8—37.2)

(20.9—24)

n= 4

n= 3

n= 0

n= 3

Previous pregnancy

n= 2

n= 6

n= 3

n= 3

Prior GDM

n= 1

n= 0

n= 0

n= 0

Asthma (n= 2)

Hypothyroid (n= 2)

Hypothyroid (n= 1)

Hypothyroid (n= 1)

Inflammatory Bowel

Coccyx nerve pain

Syndrome (n= 1)

(n= 1)

Age (years)

Physical activity
guidelines met

Medical conditions

Depression (n= 1)
Complications in
previous pregnancy

N/A

Depression (n= 1)
Scoliosis (n= 1)
Pre-eclampsia
(n= 1)

Depression (n= 1)

Coccyx nerve pain
(n= 1)

Scoliosis (n= 1)

Depression (n= 1)

Pre-eclampsia (n=1)

n= 0

Note: Non-Pregnant (n =7), Pregnant (n =7) with a sub-grouping of Normoglycaemia (n= 3) and
Gestational Diabetes Mellitus (GDM, n= 4). Age, Gestation and Body Mass Index (BMI) are presented as
the mean and range. All other values show incidence.
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4.1.2 Adverse events
No participants had low baseline blood glucose levels that required an intake of carbohydrate
prior to commencing exercise during any phase of the study. Furthermore, no blood glucose
levels either during or post-exercise were observed below 4.0 mmol.L-1. There were no
reported episodes or symptoms of hypoglycaemia during or post-exercise, nor throughout the
full duration of any participant’s trials. The downloaded data from CGM did identify blood
glucose readings indicative of low blood sugar (<3.5 mmol.L-1) for several individuals during
overnight recordings. These low overnight readings occurred in participants in both groups
(and were not only those with GDM), did not occur repeatedly in the same individual, and
were not associated with any symptoms or adverse outcomes.

Two participants (non-pregnant) experienced a brief episode of light-headedness during one
insertion of the CGM. Both were rested in a supported seated posture in a chair in the
laboratory and monitored for 10-minutes. Their blood pressures were within normal ranges,
and no further signs or symptoms followed. One pregnant participant reported symptoms of
light-headedness towards the end of the recovery phase of one trial (continuous exercise). This
had been anticipated due to her measured low blood pressure during Phase 1, which she
reported as normal based on similar experiences in her previous pregnancy. The participant
was able to complete the recovery phase seated on the ergometer and was then assisted in
moving to a supported chair, where blood pressure and heart rate monitoring continued, and
water was provided until reported symptoms had subsided, and blood pressure and heart
rate readings were within the resting range. No other adverse events or abnormal responses
were observed or reported during baseline, exercise or recovery monitoring periods
throughout the study.
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4.2 Glycaemic control
4.2.1

Baseline – Day 1

No difference (p= 0.37) in baseline mean 24-hour blood glucose (BGL) was observed between
pregnant women (5.26 mmol.L-1 (CI 4.99, 5.54), and non-pregnant women (5.42 mmol.L-1 (CI
5.18, 5.66). Similarly, no difference (p= 0.56) was observed in overnight BGL (5.07 mmol.L-1 (CI
4.64, 5.50) and 4.89 mmol.L-1 (CI 4.52, 5.26), and fasting BGL (p= 0.98), (5.29 mmol.L-1 (CI 4.93,
5.64) and 5.29 mmol.L-1 (CI 5.01, 5.57) between pregnant and non-pregnant women,
respectively. In comparison to reference values for optimal glycaemic target levels, both
groups had relatively normal glycaemic control.

4.2.2

Exercise - acute blood glucose responses

A significant interaction (protocol x time) between protocol type (Continuous versus
Discontinuous) and time (pre-exercise, immediately post-exercise, and 15 minutes postexercise) on acute changes in BGL was observed in both pregnant (p= 0.020) and non-pregnant
(p= 0.008) group (presented in Table 4.2).

The effects of continuous and discontinuous exercise were analysed for each participant group
to determine their effect on acute blood glucose changes over time (between pre-exercise,
immediate post-exercise, and 15 min post-exercise, presented in Table 4.2). In pregnant
women, the reduction in blood glucose showed a significant interaction over time for both
Continuous (F (2,12) = 5.476; p= 0.020) and Discontinuous exercise (F (2,12) = 7.838; p= 0.008).
This has been presented in Figure 4.1. Post-hoc analysis showed that there was a trend
towards significance for reduction in blood glucose from baseline to the time-point
immediately post-exercise within both protocols (continuous: F (2,12) = 5.476 p= 0.067) and
discontinuous: (F (2,12) = 7.838, p=0.059). Acute BGL was reduced by 10.1% following
discontinuous exercise from 5.67 mmol.L-1(SD 0.47) to 5.1 mmol.L-1 (SD 0.62) (p= 0.008), and by
4.9% following continuous exercise, from 5.24 mmol.L-1 (SD 0.42) to 4.99 mmol.L-1 (p= 0.020).

For non-pregnant women, the interaction over time was significant for Continuous exercise (F
(2,12) = 6.492, p= 0.012), but not for Discontinuous exercise (F (2,12) = 2.024, p=0.175) for BGL
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changes across baseline, immediate post-exercise and 15 minutes post-exercise time points
(Figure 4.1). However, post-hoc analysis in the non-pregnant group did not show any
significance (or trend close to significance) for BGL reduction following either protocol for any
specific time point (immediate or 15 minutes post-exercise). Figure 4.1 depicts a similar
pattern of acute BGL reduction observed in pregnant and non-pregnant women for the
Continuous protocol; however, the blood glucose changes for the Discontinuous exercise in
non-pregnant women do not follow the same pattern as observed in pregnant women.

The 1-hour post-prandial BGL in response to a standard snack is presented in Table 4.3. No
interaction (protocol x time) was observed on post-prandial BGL responses between Day 1 (no
exercise) and Day 2 (following exercise, with snack consumed 15 minutes post-exercise) in
either pregnant or non-pregnant women (Table 4.3).

However, when participant groups were pooled to compare direct effects of the exercise
protocols only, there was a significantly lower 1-hr post prandial BGL following exercise on
Day 2 for both protocols, compared to Day 1. This data is presented in Table 4.4.

4.2.3

Exercise – 24-hour glycaemic control

Mean, standard deviation and coefficient of variation results for 24-hour blood glucose data
(following each exercise protocol) are presented in Table 4.3. No significant interaction (group
x time) for either exercise protocol was observed in mean 24-hour blood glucose before and
after exercise. Similarly, there was no differences observed in measures of 24-hour variability
of blood glucose levels after exercise, when compared to variability observed in baseline 24-hr
BGL. Two other clinical measures of glucose control, fasting BGL and post-prandial (1-hour)
BGL for a meal that was consumed more than 10 hours after the exercise bout were also not
influenced by maternal status over time (Table 4.3). Therefore, for exercise protocol and
maternal status, no significant change in blood glucose level, blood glucose variability, be it
fasting or post-meal state, were observed in the 24-hour post-exercise period.
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However, when participant groups were pooled to analyse the overall effect of the two
different exercise protocols on acute blood glucose responses, there were significant
differences observed. Pooled data comparing the effects of continuous and discontinuous
exercise protocols on all blood glucose measures is presented in Table 4.4. Discontinuous
exercise significantly increased mean 24-hr blood glucose level, however, this effect was not
observed for the continuous protocol. Exercise also significantly modified BGL 24-hr
variability. Continuous exercise significantly lowered the standard deviation of 24-hr BGL by
16.68%, from 0.74 mmol.L-1 (CI 0.60, 0.88) on Day 1 to 0.62mmol.L-1 (CI 0.43, 0.80) on Day 2.
Following Discontinuous exercise (p= 0.002), 24-hour BGL standard deviation was also
reduced significantly from 0.7609 mmol.L-1 (CI 0.6332, 0.8885) on Day 1 (exercise) to 0.53
mmol.L-1 (CI 0.46, 0.60) on Day 2, a 19.06% reduction. The coefficient of variation for 24-hour
BGL was significantly reduced in the Discontinuous exercise condition only, lowered by
33.51% from Day 1 (14.28% (CI 11.26, 17.30) to Day 2 (9.39% (CI 8.30, 10.49). Additionally, only
Discontinuous exercise was associated with a significant increase in overnight mean BGL but
a significant reduction in the overnight BGL variability. Interestingly, when compared to the
minimum BGL measured overnight on Day 1 (prior to exercise), higher overnight minimum
BGL were observed following exercise for both Continuous and Discontinuous exercise
protocols (Table 4.3).
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Table 4.2 Acute blood glucose responses to exercise
Acute Exercise BGL

Pre-exercise

changes (mmol.L-1)

Immediate post

15-min post

One-way ANOVA

Bonferroni multiple
comparisons

Continuous

5.24

4.86,
5.63

4.99

4.59
5.38

4.99

4.55,
5.42

P= 0.02
F (2, 12) = 5.48

P = 0.67 (-0.19, 0.53)

Discontinuous

5.67

5.24,
6.10

5.10

4.53
5.67

5.40

4.83,
5.98

P= 0.008
F (2, 12) = 4.48

P = 0.59 (-0.23, 1.17)

Continuous

5.56

4.62,
6.55

5.13

4.45
5.81

5.16

4.37,
5.95

P= 0.012
F (2, 12) = 6.49

P = 0.14 (-0.14, 1.05)

Discontinuous

5.60

5.05,
6.15

5.31

4.95
5.68

5.400

4.91,
5.72

P= 0.18
F (2, 12) = 2.02

P = 0.26 (-0.17, 0.74)

Pregnant women

Non-pregnant women

Note: Data presented was analysed one-way ANOVA, with Bonferroni multiple comparisons and P<0.05.
Non-Pregnant (n = 7), Pregnant (n = 7), with all measures presented as mean, 95% confidence intervals (CI).
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Table 4.3 Glycaemic measures over time in response to exercise, relative to pregnancy condition and protocol type.
GLYCAEMIC
MEASURE

PROTOCOL

24-HOUR BGL
24hr mean (mmol.L-1)
24hr SD ( mmol.L-1)

24hr CV (%)

Overnight mean (mmol.L-1)

Overnight SD ( mmol.L-1)
Overnight minimum
( mmol.L-1)

PREGNANT

NOT PREGNANT

Pregnancy x time

Day 1 - control

Day 2 - intervention

Day 1- control

Day 2 - intervention

Mean

Mean

Mean

Mean

+

95% CI

+

95% CI

+ 95% CI

+

95% CI

Discontinuous

Continuous

5.21

4.75, 5.68

5.50

5.23, 5.76

5.38

4.89, 5.86

5.39

5.060, 5.73

P= 0.212

P= 0.816

Discontinuous

5.32

4.87, 5.76

5.59

5.27, 5.92

5.46

5.17, 5.75

5.70

5.449, 5.94

F (1, 12) = 1.735

F (1, 12) = 0.057

Continuous

0.58

0.49, 0.68

0.46

0.30, 0.62

0.89

0.68, 1.11

0.77

0.423, 1.12

P= 0.969

P= 0.581

Discontinuous

0.78

0.50, 1.06

0.51

0.43, 0.60

0.75

0.64, 0.85

0.55

0.421, 0.68

F (1, 12) = 0.001

F (1, 12) = 0.321

Continuous

11.24

9.41, 13.06

9.35

7.28, 11.43

16.95

11.97, 21.94

14.50

6.99, 22.01

P= 0.820

P= 0.530

Discontinuous

14.96

8.43, 21.49

9.18

7.63, 10.73

13.60

10.91, 16.29

9.61

7.57, 11.65

F (1, 12) = 0.054

F (1, 12) = 0.417

Continuous

5.00

4.31, 5.69

5.31

4.93, 5.68

4.84

4.12, 5.55

5.15

4.48, 5.83

P= 0.987

P= 0.401

Discontinuous

5.14

4.41, 5.87

5.40

5.03, 5.78

4.94

4.44, 5.45

5.46

5.14, 5.78

F (1, 12) = 0.0002

F (1, 12) = 0.757

Continuous

0.34

0.25, 0.43

0.36

0.22, 0.51

0.48

0.34, 0.61

0.45

0.11, 0.79

P= 0.782

P= 0.913

Discontinuous

0.45

0.29, 0.62

0.32

0.19, 0.45

0.43

0.32, 0.55

0.29

0.18, 0.40

F (1, 12) = 0.080

F (1, 12) = 0.013

Continuous

4.27

3.61, 4.93

4.73

4.45, 5.01

3.83

2.81, 4.85

4.56

3.90, 5.22

P= 0.605

P= 0.670

Discontinuous

4.33

3.40, 5.26

4.99

4.66, 5.31

4.14

3.65, 4.63

4.99

4.63, 5.34

F (1, 12) = 0.282

F (1, 12) = 0.191

Exercise protocol x time

ACUTE BGL RESPONSES

Fasting – 1hr mean

Continuous

5.30

4.71, 5.89

5.30

4.91, 5.70

5.19

4.62, 5.76

4.84

4.23, 5.46

(mmol.L-1)

Discontinuous

5.27

4.68, 5.87

5.32

4.94, 5.69

5.39

5.08, 5.70

5.48

5.29, 5.66

Continuous

5.61

4.95, 6.28

5.53

5.10, 5.96

5.51

5.06, 5.97

5.10

4.41, 5.79

Discontinuous

5.67

5.26, 6.08

5.46

5.08, 5.84

5.70

5.33, 6.07

5.69

5.46, 5.91

1hr post prandial – mean

Continuous

6.30

5.73, 6.87

5.57

5.23, 5.92

7.00

6.62, 7.38

5.47

4.63, 6.31

(mmol.L-1) Post-exercise

Discontinuous

6.16

5.42, 6.90

5.76

5.12, 6.39

6.96

6.62, 7.30

5.94

5.53, 6.36

1-hr post prandial - mean

Continuous

5.74

4.56, 6.93

6.01

5.27, 6.76

6.30

5.69, 6.91

6.07

5.53, 6.62

(mmol.L-1) Main meal

Discontinuous

6.67

5.53, 7.82

6.49

5.71, 7.29

6.37

5.96, 6.78

6.96

5.84, 7.33

1-hr post prandial – peak

Continuous

5.87

4.75, 6.99

6.84

6.29, 7.40

6.79

5.85, 7.72

6.40

5.70, 7.10

(mmol.L-1) Main meal

Discontinuous

6.77

5.65, 7.89

6.64

5.85, 7.44

6.90

6.44, 7.37

6.30

5.56, 7.04

Fasting – peak (mmol.L-1)

Continuous

Note: Data presented was analysed by two-way ANOVA (repeated measures) with post-hoc Tukey and P <0.05.
Non-Pregnant (n = 7), Pregnant (n = 7), with all measures presented as mean, 95% confidence intervals (CI).
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Pregnant

Not pregnant

P= 0.898
F (1, 6) = 0.018

P= 0.361
F (1, 6) = 0.978

P= 0.735
F (1, 6) = 0.126

P= 0.441
F (1, 6) = 0.682

P= 0.367
F (8, 48) = 1.120

P= 0.506
F (8, 48) = 0.923

P= 0.448
F (1, 6) = 0.660

P= 0.352
F (1, 6) = 1.020

P= 0.396
F (1, 6) = 0.836

P= 0.471
F (1, 6) = 0.591

Table 4.4 Comparison of Continuous and Discontinuous exercise on glycaemic measures in all participants.

GLYCAEMIC
MEASURE

CONTINUOUS EXERCISE
Day 1 - control

Day 2 - intervention

DISCONTINUOUS EXERCISE
Day 1 - control

Day 2 - intervention

24-HOUR BGL

Mean

95% CI

Mean

24hr mean (mmol.L-1)

5.29

5.00, 5.58

5.44

5.26, 5.63

5.39

0.40, 0.11

5.64

5.47, 5.82

24hr SD ( mmol.L-1)

0.74

0.60, 0.88

0.62

0.43, 0.80

0.76

0.63, 0.89

0.53

0.46, 0.60

24hr CV (%)

14.10

11.27, 16.92

11.93

8.28, 15.57

14.28

11.26, 17.30

9.39

8.30, 10.49

Overnight mean ( mmol.L-1)

4.92

4.49, 5.34

5.23

4.90, 5.56

5.04

4.66, 5.42

5.43

5.22, 5.64

Overnight SD ( mmol.L-1)

0.42

0.33, 0.49

0.407

0.25, 0.57

0.44

0.36, 0.53

0.31

0.23, 0.38

Overnight minimum
(mmol.L-1)

4.05

3.52, 4.58

4.64

4.33, 4.95

4.24

3.79, 4.68

4.99

4.78, 5.19

5.25

4.90, 5.60

5.07

4.73, 5.41

5.33

5.04, 5.62

5.40

5.21, 5.58

Fasting – peak (mmol.L-1)

5.56

5.22, 5.91

5.31

4.95, 5.68

5.69

5.45, 5.92

5.57

5.37, 5.77

1hr post prandial – mean
(mmol.L-1) Snack

6.65

6.29, 7.01

5.52

5.14, 5.91

6.56

6.14, 6.98

5.85

5.52, 6.18

6.02

5.43, 6.61

6.04

5.65, 6.43

6.52

6.00, 7.05

6.54

6.08, 6.99

6.33

5.65, 7.00

6.62

6.22, 7.02

6.84

6.32, 7.35

6.47

6.00, 6.95

+ 95% CI

Mean

+

+ 95% CI

Mean

Pooled Data
Continuous

Discontinuous

P= 0.167
(t=1.463 df=13)
P=0.048
(t=2.178 df=13)
P=0.090
(t=1.833 df=13)
P=0.164
(t=1.476 df=13)
P=0.979
(t=0.027 df=13)

P=0.007
(t=3.195 df=13)
P=0.002
(t=3.852 df=13)
P=0.003
(t=3.600 df=13)
P=0.018
(t=2.702 df=13)
P=0.009
(t=3.093 df=13)

+ 95% CI

P=0.033

P=0.003

(t=2.387 df=13)

(t=3.643 df=13)

ACUTE BGL RESPONSES
Fasting – 1hr mean
(mmol.L-1)

1-hr post prandial - mean
(mmol.L-1) Main meal
1-hr post prandial – peak
(mmol.L-1) Main meal

P= 0.493
(t=0.7049 df=13)
P= 0.349
(t=0.972 df=13)

P= 0.511
(t=0.6757 df=13)
P= 0.311
(t=1.055 df=13)

P= 0.0004
(t=4.737 df=13)
P= 0.919
(t=0.103 df=13)

P= 0.004
(t=3.558 df=13)
P= 0.956
(t=0.057 df=13)

P= 0.406
(t=0.860 df=13)

P= 0.239
(t=1.234 df=13)

Note: Data presented was analysed by Paired t-tests (two-tailed), with significance of P <0.05.
Pregnant and non-pregnant women were pooled (n= 14), with all measures reported as mean, with 95% confidence intervals (CI).
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Figure 4.1 * indicates significant change (p <0.05).
Acute blood glucose changes are shown from baseline pre-exercise to immediate post-exercise
and 15-minute post-exercise, presented as mean (central line) and 95% confidence intervals
(bars). Pregnant women (top graph) had a significant interaction over time, measured by oneway ANOVA for both Continuous (p= 0.020) and Discontinuous (p= 0.008) exercise, showing a
reduction in blood glucose. Non-pregnant women (bottom graph) had a significant interaction
for Continuous exercise only (p= 0.012).
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4.3

Metabolic gas exchange measures

4.3.1

Baseline (pre-exercise) gas exchange

No significant interactions between pregnancy and exercise protocol (group x protocol) were
observed for any resting metabolic measures (Figure 4.2, Table 4.5). When just the resting

.

period prior to each protocol was examined, there was no significant difference in resting VO2
between pregnant women and non-pregnant women prior to the Continuous protocol or the
Discontinuous protocol (Figure 4.2).. Respiratory exchange ratio (RER) prior to the Continuous
protocol also did not differ at rest between pregnant women and non-pregnant women.
However, prior to the Discontinuous protocol, RER was significantly higher in the pregnant

.

group compared to non-pregnant. Resting minute ventilation ( V E) before the Continuous
protocol was higher in the pregnant group compared to non-pregnant women and similarly
before the Discontinuous protocol a significant difference was found between pregnant women
and non-pregnant women.

When participants were pooled to permit specific comparison between the protocols only, there

.

.

was no difference in resting VO2, RER or VE due to exercise protocol (Table 4.6).

4.3.2

Exercising gas exchange

Overall, exercising oxygen consumption was not significantly different between the two
exercise protocols (Figure 4.2). No interaction (p= 0.648, group x protocol) was found between

.

pregnancy condition and the protocol type. Mean V O2 was 0.768 L.min-1 (CI 0.621, 0.915)
during Continuous exercise and 0.738 L.min-1 (CI 0.583, 0.893) during Discontinuous exercise.
This demonstrated that the total metabolic work completed by participants was equivalent. A
representative example of this for an individual participant is shown in Figure 4.3. Furthermore,
it reflects that any differences in the physiological responses to the two protocols are more likely
attributed to the effect of exercise intensity (low vs. moderate), structure (Continuous vs.
Discontinuous), or the combination of both, rather than the metabolic work of the exercise. No

.

interaction (group x protocol) was observed for RER or VE (Table 4.5).
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.

When participants were pooled (presented in Table 4.6), the VO2 for each exercise protocol

.

remained similar (p= 0.373), with Continuous V O2 (0.747 L.min-1 (CI 0.651, 0.843) and

.

Discontinuous VO2 (0.728 L.min-1 (CI 0.635, 0.820). RER was observed to be significantly higher
(p< 0.0001) during Discontinuous exercise compared to Continuous exercise. No difference was

.

observed for VE between the two exercise protocols among pooled participants.

4.3.3

Acute recovery gas exchange

There were no significant interactions between pregnancy condition and type of exercise

.

.

(protocol) for recovery VO2 (Figure 4.2), RER or VE (presented in Table 4.5).

When participants were pooled, there were no significant differences in the effects of
discontinuous vs. continuous exercise for any recovery metabolic measures (presented in Table
4.6). However, differences were found when comparing recovery to the baseline period prior to

.

exercise. For Continuous exercise, post-exercise V O2 (or excess post-exercise oxygen
consumption, EPOC) was significantly higher during recovery than at baseline).

For

Discontinuous exercise, the difference was not significant between resting level and recovery

.

level. Similarly, following continuous exercise, recovery minute ventilation ( V E) was
significantly higher than the baseline measure. Yet the difference was not significant for
Discontinuous exercise. In contrast, both Continuous and Discontinuous protocols had a
significantly higher RER during recovery compared to baseline RER.
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Table 4. 5: Effects of Continuous and Discontinuous exercise on metabolic responses during rest, exercise and recovery, relative to pregnancy condition
PREGNANT
PROTOCOL
Metabolic responses
Continuous

Rest
Mean
0.89

RER

VE
(L.min )

Discontinuous

0.91

Continuous

11.63

-1

RPE – All
(6-20)

RPE –

Discontinuous

11.92

Continuous

-

Discontinuous
Continuous

-

Exercise
+ 95% CI
0.85
0.94
0.86
0.96
10.35
12.91
0.45
13.39
-

Mean
0.92

1.01

26.44

26.45
9.6
10.8
9.7

Legs
(6-20)

Recovery

+ 95% CI
0.87
0.98
0.93
1.08
21.54
31.34
22.03
30.86
8.83
10.43
9.38
12.22
7.98
11.50

Pregnancy x Protocol

NOT PREGNANT

Mean
0.94

0.96

13.41

12.56
-

Rest

+ 95% CI
0.90
0.98
0.09
0.03
11.43
15.39
10.80
14.33
-

Mean
0.85

0.84

9.06

9.10
-

+ 95% CI
0.79
0.91
0.82
0.87
7.72
10.40
8.18
10.03
-

Exercise

Recovery

Mean

Mean

0.88

0.94

21.49

21.37
8.71

-

-

-

-

9.59

-

-

-

-

8.69

+ 95% CI
0.85
0.90
0.90
0.98
18.57
24.42
17.68
25.07
7.24
10.19
8.02
11.15
7.32
10.05

0.90

0.89

10.73

9.55
-

REST

0.87
0.92

-

-

11.6

9.50
13.67

-

-

-

-

9.97

8.48

0.86
0.93

P= 0.44

P= 0.43

F (1, 12) =

F (1, 12) =

F (1, 12) =

0.40

0.63

0.68

P= 0.77

P= 0.93

P= 0.78

F (1, 12) =

F (1, 12) =

F (1, 12) =

0.09

0.01

0.08

8.57
12.88
8.61
10.48
-

P= 0.65
-

-

-

-

-

11.47

-

REC

P= 0.54

-

F (1, 12) =

P= 0.11
F (1, 12) =
3.04

Note: Data presented was analysed by two-way ANOVA (repeated measures), with P<0.05.
Non-Pregnant (n = 7), Pregnant (n = 7), with all measures presented as mean, 95% confidence intervals (CI).
Rest = 5 min pre-exercise (REST), exercise = 30-min exercise bout (EX), recovery =10 min post-exercise (REC), RPE = rating of perceived exertion (6-20 scale).
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-

0.22

-

Discontinuous

EX

+ 95% CI

-

Table 4.6 Comparison of Continuous and Discontinuous exercise on metabolic responses, with pregnant and non-pregnant women pooled (n= 14)
Metabolic
responses
V02
(L.min-1)

RER
VE
(L.min-1)

CONTINUOUS
Rest

Exercise

Pooled Results

DISCONTINUOUS
Recovery

Rest

Exercise

Recovery

REST

EX

REC

0.25
0.29

P= 0.91
t=0.12 df=13

P= 0.37
t=0.92 df=13

P= 0.08
t=1.89 df=13

0.93

0.88
0.97

P= 0.82
t=0.23 df=13

P< 0.0001
t=6.21 df=13

P= 0.66
t=0.45 df=13

11.05

9.82
12.29

P= 0.68
t=0.42 df=13

P= 0.93
t=0.09 df=13

P= 0.10
t=1.80 df=13

Mean

+ 95% CI

Mean

+ 95% CI

Mean

+ 95% CI

Mean

+ 95% CI

Mean

+ 95% CI

Mean

+ 95% CI

0.27

0.24
0.30

0.75

0.65
0.84

0.30

0.26
0.35

0.27

0.26
0.29

0.73

0.64
0.82

0.27

0.97

0.93
1.01

23.91

21.03
26.79

0.87

10.34

0.84
0.91
9.24
11.45

0.90

23.97

0.87
0.93
21.13
26.80

0.92

12.07

0.89
0.94
10.59
13.54

0.88

10.51

0.84
0.91
9.39
11.63

Note: Data presented was analysed by Paired t-tests (two-tailed), with significance of P<0.05. All measures are reported as mean, with 95% confidence intervals (CI).
Pregnant and non-pregnant women were pooled (n= 14).
Rest = 5 min pre-exercise (REST), exercise = 30-min exercise bout (EX), recovery =10-min post-exercise (REC).
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Figure 4.2 This graph shows the mean oxygen consumption levels (with 95%
confidence interval bars) at rest, during exercise (30 min Ex) and during recovery.
There was no significant difference observed between pregnant and non-pregnant
women, for either protocol.

Figure 4.3 Representative data from one participant depicts comparable oxygen
consumption (VO2 L.min-1) and heart rate (HR, beats per min) between the two
different exercise protocols.
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4.4 Heart rate variability
4.4.1

Resting HRV measures

At baseline, there were significant differences between pregnant and non-pregnant women
observed for several resting HRV measures (Table 4.7). Time-domain measures of pNN50
(p=0.0388) and RMSSD (p=0.0304) were significantly higher at rest in the non-pregnant group
(pNN50 (27.46% (CI 4.488, 50.44), RMSSD (50.39 ms (CI 25.15, 75.63) compared to the pregnant
group (pNN50 (1.91% (CI -1.037, 4.859), RMSSD (16.10 ms (CI 8.793, 23.40). The high
frequency (HF) spectral component, measured as absolute power and presented in normalised
units, was also significantly higher (p= 0.0353) among non-pregnant women (6.444 n.u (CI
5.259, 7.629) than pregnant women (4.407 n.u (CI 3.456, 5.358). No further differences in the
resting frequency-domain measures between groups were found. Mean heart rate at rest was
higher (p= 0.0204) in pregnant participants at 86.37 bpm (CI 78.62, 94.12) than non-pregnant
participants at 69.28 bpm (CI 61.56, 76.99). The mean interval between QRS complexes (mean
R-R) was significantly shorter (p= 0.0158) in pregnant women at 701.8 ms (CI 641.2, 762.3)
compared to non-pregnant women at 881.2 ms (CI 792.1, 970.4).

Table 4.7 Time and Frequency domain HRV measures at rest in pregnant and non-pregnant women.
HRV MEASURE

PREGNANT

NOT PREGNANT

Time
Heart rate (bpm)

86.3

78.6, 94.1

69.3

61.6, 77.0

P= 0.02 (t=3.13, df=6)

R-R interval (ms)

701.8

641.2, 762.3

881.2

792.1, 970.4

P= 0.016 (t=3.33, df=6)

pNN50 (%)

1.91

-1.04, 4.99

27.46

4.489 50.44

P= 0.04 (t=2.63, df=6)

RMSSD (ms)

16.10

8.79, 23.40

50.39

25.15, 75.63

P= 0.03 (t=2.82, df=6)

SDNN (ms)

32.80

17.52, 48.09

64.91

43.09, 86.73

P= 0.06 (t=2.35, df=6)

Frequency
LF peak (n.u)

-2.74

-2.99, -2.50

-2.51

-2.93, -2.09

P= 0.32 (t=1.08, df=6)

LF absolute (n.u)

5.55

4.56, 6.54

6.65

5.63, 7.66

P= 0.20 (t=1.445, df=6)

LF relative (%)

33.96

25.25, 42.67

28.95

14.57, 43.32

P= 0.52 (t=0.69, df=6)

HF peak (n.u)

-1.35

-1.66, -1.05

-1.49

-1.75, -1.23

P= 0.51 (t=0.701, df=6)

HF absolute (n.u)

4.41

3.46, 5.36

6.44

5.26, 7.63

P= 0.035 (t=2.71, df=6)

HF relative (%)

12.34

4.82, 19.86

23.65

11.91, 35.38

P= 0.14 (t=1.71, df=6)

LF/HF

3.85

1.54, 6.17

1.84

0.40, 3.29

P= 0.14 (t=1.72, df=6)

TP 5 min (ms)

6.67

5.84, 7.50

8.03

7.19, 8.86

P= 0.07 (t=2.20, df=6)

VLF peak (n.u)

-4.94

-5.72, -4.16

-4.68

-5.37, -3.99

P= 0.46 (t=0.79, df=6)

VLF absolute (n.u)

6.03

5.21, 6.85

7.24

6.45, 8.03

P= 0.09 (t=2.01, df=6)

VLF relative (%)

53.67

43.27, 64.07

47.36

34.65, 60.08

P= 0.44 (t=0.82, df=6)

Note: Data presented was analysed by Paired t-tests (two-tailed), with significance of P<0.05.
Non-Pregnant (n = 7), Pregnant (n = 7). All measures are reported as mean, with 95% confidence intervals (CI)
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4.4.2

Exercising responses due to protocol

A significant interaction (group x protocol) was observed for the RMSSD Time Domain measure
(p= 0.02) between pregnancy and type of exercise during a single bout of exercise. During
Continuous exercise, RMSSD in non-pregnant women was 38.1%higher at 15.15ms (CI 9.08,
21.21) compared to pregnant women at 9.39 ms (CI 0.85, 17.92). In contrast, RMSSD during
Discontinuous exercise was 25.2% higher in pregnant women at 12.31 ms (CI -1.61, 26.24) than
the non-pregnant women at 9.21 ms (5.78, 12.64), however there were no post-hoc differences
found. No other interactions (group x protocol) were found for time-domain measures during
acute exercise (Table 4.8). For Frequency Domain measures, there was a significant interaction
(group x protocol) in the low frequency (LF) spectral component (p= 0.03). During Continuous
exercise, LF (absolute power) was 30.6% greater in non-pregnant women (5.06 n.u (CI 4.53,
5.61) than pregnant women (3.15 n.u (CI 2.03, 5.00). This interaction remained significant with
post-hoc comparisons. However, during Discontinuous exercise, LF (absolute power) was 5.9
% greater in pregnant women (5.50 n.u (CI 4.22, 6.77) than in non-pregnant women (5.17 n.u
(CI 4.45, 5.89). There was no post-hoc differences found for discontinuous exercise. No other
interactions (group x protocol) were observed for frequency-domain measures during acute
exercise (Table 4.8).

When participant groups were pooled to allow a specific comparison of only the exercise
protocol responses, SDNN was significantly higher (p= 0.01) during Discontinuous exercise
than during Continuous exercise. However, no other time domain variables were found to be
significantly different between the two protocols. This data is presented in Table 4.9.
Significant differences were also observed with respect to the frequency domain. The LF
absolute power measure was significantly greater (p< 0.0001) during Discontinuous exercise
compared to Continuous exercise. In contrast, both peak LF and relative LF were significantly
greater (p< 0.0001 and p= 0.0073 respectively) during Continuous exercise than during
Discontinuous exercise. The HF relative power was also higher (p= 0.0018) during the
Continuous exercise compared to Discontinuous exercise, while the LF/HF ratio was greater
(p= 0.0267) in Discontinuous exercise compared to Continuous exercise. However, neither
peak HF nor absolute HF were significantly different between the exercise protocols (Table
4.9).
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4.4.3

Acute recovery responses

No significant interactions (group x protocol) were found between pregnancy condition and
protocol type for any time-domain or frequency domain measures during the recovery period
(captured between minute-3 and minute-7-following exercise (Table 4.8).

When participants were pooled, there was no significant difference in any HRV measures
during recovery between Continuous and Discontinuous exercise (Table 4.9).
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Table 4.8 Heart rate variability responses with exercise, related to pregnancy and type of exercise protocol performed.
HRV MEASURE

PROTOCOL

Time domain

PREGNANT
Recovery

Mean

Mean

+ 95% CI

Pregnancy x protocol

NOT PREGNANT

Exercise

Exercise

+ 95% CI

Mean

Recovery

+ 95% CI

Mean

EXERCISE

RECOVERY

+ 95% CI

Heart rate (bpm)

Continuous
Discontinuous

113.0
122.4

99.9, 126
110.7, 134

90.7
97.5

76.5, 104.8
89, 106

96.7
108.5

88.4, 105
90.7, 126.3

77.3
78.6

65.3, 89
67.4, 89.8

P= 0.75
F (1, 12) = 0.11

P= 0.26
F (1, 12) = 1.4

R-R interval (ms)

Continuous
Discontinuous

538.6
499.8

479, 598.2
448.2, 551.5

754.9
623.7

500.9, 1009
567.4, 680.1

625.7
575.4

575.8, 675.7
455.3, 695.5

799.8
785.3

685.7, 913.9
664.5, 906.1

P= 0.81
F (1, 12) = 0.06

P= 0.27
F (1, 12) = 1.32

pNN50 (%)

Continuous
Discontinuous

0.85
1.70

-1.23, 2.93
-1.65, 5.05

6.08
4.43

-0.67, 12.84
-3.19, 12.05

0.89
0.54

0.05, 1.73
-0.11, 1.2

20.03
20.5

3.22, 36.84
-0.43, 41.43

P= 0.09
F (1, 12) = 3.48

P= 0.79
F (1, 12) =0.08

Continuous
Discontinuous

9.39
12.31

0.85, 17.92
-1.61, 26.24

23.65
24.70

6.79, 40.51
-3.51, 52.91

15.15
9.21

9.08, 21.21
5.78, 12.64

37.9
45.44

19.04, 56.77
10.8, 80.08

P= 0.020
F (1, 10) = 7.70

P= 0.714
F (1, 10) = 0.14

Continuous

14.63

7.85, 21.41

38.01

24.22, 51.79

22.16

15.23, 29.09

58.42

33.41, 83.43

Discontinuous

44.71

11.62, 77.79

35.94

12.4, 59.48

44.49

9.07, 79.9

62.41

37.36, 87.46

P= 0.64
F (1, 10) = 0.24

P= 0.72
F (1, 10) = 0.14

LF peak (n.u)

Continuous
Discontinuous

-2.50
-2.98

-2.68, -2.32
-3.10, -2.86

-2.64
-2.92

-3.00, -2.29
-3.15, -2.68

-2.58
-3.00

-2.90, -2.25
-3.15, -2.85

-2.72
-2.52

-2.97, -2.48
-2.78, -2.26

P= 0.77
F (1,12) = 0.09

P= 0.07
F (1, 12) = 4.11

LF absolute (n.u)

Continuous
Discontinuous

3.52
5.50

2.03, 5.00
4.22, 6.77

6.93
5.24

4.55, 9.31
3.77, 6.72

5.06
5.17

4.52, 5.61
4.45, 5.89

6.68
7.18

5.70, 7.65
6.53, 7.82

P= 0.03
F (1, 12) = 6.05

P= 0.138
F (1, 12) = 2.52

LF relative (%)

Continuous
Discontinuous

33.04
23.95

20.16, 45.92
11.19, 36.71

34.31
26.83

20.37, 48.26
14.97, 38.69

39.47
17.83

27.08, 51.87
10.57, 25.10

34.11
39.85

24.73, 43.48
23.80, 55.90

P= 0.21
F (1, 12) = 1.79

P= 0.07
F (1, 12) = 3.89

HF peak (n.u)

Continuous
Discontinuous

-1.55
-1.83

-1.92, -1.17
-1.94, -1.71

-1.54
-1.49

-1.75, -1.32
-1.79, -1.20

-1.39
-1.48

-1.75, -1.02
-1.77, -1.19

-1.48
-1.58

-1.73, -1.24
-1.82, -1.33

P= 0.14
F (1, 12) = 2.51

P= 0.14
F (1, 12) = 2.51

HF absolute (n.u)

Continuous
Discontinuous

2.58
3.72

0.72, 4.44
2.58, 4.86

6.02
4.56

3.43, 8.61
3.04, 6.09

4.05
3.91

3.15, 4.95
3.36, 4.46

6.14
6.58

4.90, 7.39
5.58, 7.58

P= 0.15
F (1, 12) = 2.34

P= 0.20
F (1, 12) = 1.85

HF relative (%)

Continuous
Discontinuous

16.00
4.06

4.14, 27.86
2.24, 5.88

15.17
16.04

6.60, 23.74
3.62, 28.46

14.44
5.80

9.43, 19.45
0.19, 11.40

22.32
22.91

11.87, 32.76
9.71, 36.11

P= 0.55
F (1, 12) = 0.37

P= 0.97
F (1,12) = 0.001

LF/HF

Continuous
Discontinuous

0.94
1.77

0.29, 1.58
1.39, 2.16

0.90
0.68

0.41, 1.39
-0.04, 1.40

1.01
1.26

0.59, 1.43
-0.22, 1.28

0.53
0.60

0.64, 1.89
-0.25, 1.45

P= 0.25
F (1, 12) = 1.44

P= 0.68
F (1, 12) = 0.18

TP (5 min) (ms)

Continuous
Discontinuous

4.74
7.04

3.62, 5.85
5.84, 8.23

8.12
6.68

5.37, 10.87
5.53, 7.83

6.04
7.08

5.34, 6.74
6.12, 8.04

7.79
8.19

6.90, 8.68
7.63, 8.75

P= 0.06
F (1, 12) = 4.29

P= 0.19
F (1, 12) = 1.93

VLF peak (n.u)

Continuous
Discontinuous

-4.76
-4.84

-5.51, -4.02
-5.17, -4.50

-5.05
-4.57

-5.66, -4.44
-5.35, -3.80

-3.48
-4.93

-5.02, -1.95
-5.25, -4.62

-4.41
-4.45

-5.18, -3.63
-5.18, -3.72

P= 0.08
F (1, 12) = 3.62

P= 0.49
F (1, 12) = 0.52

VLF absolute (n.u)

Continuous
Discontinuous

3.98
6.69

3.08, 4.88
5.45, 7.92

7.36
6.06

4.37, 10.34
5.04, 7.08

5.21
6.81

4.28, 6.15
5.74, 7.88

6.93
7.15

6.09, 7.77
6.73, 7.57

P= 0.11
F (1, 12) = 3.06

P= 0.28
F (1, 12) = 1.31

P= 0.46
F (1, 12) = 0.59

P= 0.10
F (1, 12) = 3.18

RMSSD (ms)
SDNN (ms)

Frequency domain

VLF relative (%)

Continuous

50.89

30.17, 71.61

50.45

30.05, 70.86

45.95

32.94, 58.97

43.55

32.73, 54.37

Discontinuous

71.97

58.08, 85.85

56.99

38.65, 75.32

76.35

64.92, 87.79

37.19

24.52, 49.85
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From previous page Table 4.8
Note: Data presented was analysed by two-way ANOVA (repeated measures), with P<0.05.
Non-Pregnant (n = 7), Pregnant (n = 7), with all measures presented as mean, 95% confidence intervals (CI).

Table 4.9 Heart rate variability during Continuous vs. Discontinuous exercise, with participant groups pooled.

HRV MEASURE

Pooled Data

DISCONTINUOUS

CONTINUOUS

EXERCISE

RECOVERY

EXERCISE

RECOVERY

Time domain

Mean

Mean

Heart rate (bpm)

104.8

96.6, 113.0

83.9

75.1, 92.7

115.4

105.5, 125.4

88.1

79.8, 96.3

P= 0.01 (t=3.01, df=13)

P= 0.09 (t=1.80, df=13)

R-R interval (ms)

582.2

540.1, 624.2

777.4

658.5, 896.2

537.6

477.7, 597.5

704.5

630.1, 779.0

P= 0.07(t=1.99, df=13)

P= 0.18 (t=1.42, df=13)

pNN50 (%)

0.87

-0.08, 1.82

13.06

4.310, 21.80

1.12

-0.37, 2.61

12.47

1.867 23.07

P= 0.49 (t=0.72, df=13)

P= 0.88 (t=0.16, df=13)

RMSSD (ms)

12.27

7.50, 17.03

31.32

19.69, 42.95

10.76

4.61, 16.91

37.23

16.11, 58.35

P= 0.43 (t=0.81, df=13)

P= 0.42 (t=0.83, df=12)

SDNN (ms)

18.39

13.70, 23.08

49.00

34.83, 63.17

44.60

24.04, 65.15

51.50

34.26, 68.73

P= 0.01 (t=3.012, df=13)

P= 0.67 (t=0.45, df=12)

LF peak (n.u)

-2.54

-2.70, -2.38

-2.68

-2.87, -2.50

-2.99

-3.07, -2.91

-2.72

-2.91, -2.53

P < 0.0001

LF absolute (n.u)

4.60

3.93, 5.26

6.80

5.71, 7.89

6.75

6.05, 7.44

6.21

5.31, 7.11

P < 0.0001 (t=6.30, df=13)

P= 0.43 (t=0.81, df=13)

LF relative (%)

36.26

28.43, 44.08

34.21

27.08, 41.34

20.89

14.40, 27.38

33.34

24.02, 42.66

P= 0.0073 (t=3.18, df=13)

P= 0.82 (t=0.24, df=13)

HF peak (n.u)

-1.47

-1.69, -1.24

-1.51

-1.65, -1.37

-1.65

-1.82, -1.48

-1.54

-1.70, -1.37

P= 0.13 (t=1.62, df=13)

P= 0.84 (t=0.20, df=13)

HF absolute (n.u)

3.32

2.34, 4.30

6.08

4.86, 7.30

3.82

3.28, 4.36

5.57

4.59, 6.55

P= 0.28 (t=1.14, df=13)

P= 0.49 (t=0.71, df=13)

HF relative (%)

15.22

9.74, 20.70

18.75

12.63, 24.86

4.93

2.38, 7.48

19.47

11.52, 27.43

P= 0.0018 (t=3.90, df=13)

P= 0.83 (t=0.22, df=13)

LF/HF

3.04

2.12, 3.96

2.57

1.47, 3.66

5.25

3.76, 6.74

2.43

1.56, 3.29

P= 0.03 (t=2.50, df=13)

P= 0.81 (t=0.25, df=13)

TP 5 min n(ms)

5.39

4.71, 6.07

7.95

6.72, 9.19

7.06

6.41, 7.71

7.43

6.73, 8.14

P= 0.0003 (t=4.92, df=13)

P= 0.46 (t=0.76, df=13)

VLF peak (n.u)

-4.12

-4.94, -3.31

-4.73

-5.19, -4.27

-4.89

-5.08, -4.69

-4.51

-4.97, -4.06

P= 0.08 (t=1.92, df=13)

P= 0.55 (t=0.61, df=13)

VLF absolute (n.u)

4.29

3.47, 5.11

7.14

5.82, 8.47

5.33

4.71, 5.96

6.60

6.04, 7.17

P= 0.04 (t=2.32, df=13)

P= 0.43 (t=0.81, df=13)

VLF relative (%)

48.42

37.94, 58.90

47.00

36.99, 57.01

74.16

66.42, 81.90

47.09

35.93, 58.25

P= 0.0008 (t=4.32, df=13)

P= 0.98 (t=0.02, df=13)

+ 95% CI

+ 95% CI

EXERCISE

RECOVERY

Mean

Mean

+ 95% CI

+

95% CI

Frequency domain

(t=5.69, df=13)

Note: Pooled data presented was analysed by Paired t-tests (two-tailed), with significance of P<0.05.
Pregnant and non-pregnant women were pooled (n= 14). All measures are reported as mean, with 95% confidence intervals (CI).

page 67

P= 0.80 (t=0.26, df=13)

4.5 Psychophysical measures
The rating of perceived exertion during exercise (RPE)was not affected by pregnancy, with no
interaction observed between group and type of protocol (presented in Table 4.5).

When participant groups were pooled, RPE scores for total effort (10.19 (CI 9.225, 11.16) and for
leg effort (10.78 (CI 9.588, 11.97) were both significant higher (p= 0.006 and p= 0.0005 respectively)
during the Discontinuous protocol than the Continuous protocol (9.171 (CI 8.410, 9.933) total
body, and 9.214 (CI 8.217, 10.21) - for legs).

Qualitative data from participants’ subjective reporting on their perception of the relative
difficulty of the two protocols was more varied. Four participants (3 pregnant, 1 non-pregnant)
reported that the Discontinuous protocol ‘felt moderately more difficult’, and described this as
being related to noticing a higher body temperature and changes in their heart rate; four women
reported the Discontinuous protocol as being ‘slightly more difficult’ than continuous (3 nonpregnant, 1 pregnant), while a further four reported perceiving no difference in the difficulty
between the two protocols (3 non-pregnant, 1 pregnant). The remaining two participants
reported that the Continuous protocol was ‘moderately more difficult’. Both of these women
were in the pregnancy group and described that they perceived breathing effort and overall
fatigue levels to be greater by the continuous effort without rest.

When asked which of the two exercise protocols they found more enjoyable, the majority of
participants (12/14) reported that they enjoyed the exercise experience of performing the
Discontinuous protocol more than the Continuous protocol. The reasons provided ranged from
enjoyment of working harder, feeling confident to work harder, and finding it more physically
comfortable to have rest breaks between exercising (the latter was only identified by pregnant
participants). For the two people who reported enjoying the Continuous protocol more, both
described this as related to finding the heavier workload on their legs during the discontinuous
protocol challenging, and both reported that they had not ridden a bike ‘for a while’.
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5.0 DISCUSSION
This investigation found there was a difference in the acute blood glucose responses to the two
exercise protocols over time in pregnant versus non-pregnant women. In pregnant women, 15
minutes of moderate intensity, discontinuous cycling and 30 minutes of low intensity continuous
cycling both had the effect of significantly reducing blood glucose from pre-exercise baseline
level to immediate post-exercise and remained at 15-minutes post-exercise. In non-pregnant
women, however, acute reductions in blood glucose were only found with the Continuous
protocol. For all other measures of daily glycaemic control, there were no significant effects
found for either protocol in either group.

With both groups identified as having normal daily blood glucose levels throughout the study
period, the data for pregnant and non-pregnant women were combined to allow a direct
comparison of the effects of two exercise protocols, without the primary variable of pregnancy.
When pooled, a bout of moderate intensity, discontinuous exercise resulted in different changes
to 24-hour glycaemic control compared low intensity, continuous cycling of matched total work.
Following the discontinuous protocol, the mean 24-hour blood glucose level significantly
increased but remained within the normal clinical range; while daily blood glucose variability
measures (standard deviation of BGL around the 24-hr mean; coefficient of variation of glucose)
were significantly reduced. Following the continuous protocol, however, there were no
significant effects on mean 24-hour blood glucose. Standard deviation of 24-hour blood glucose
was significantly lowered, but there was no significant change to the co-efficient of variation.
Thus, changes observed in 24-hour glycaemic control was influenced by the intensity and
structure of the preceding acute exercise bout. This suggests that, independent of total work
(energy expenditure), glycaemic control over 24-hour may be able to be augmented through the
intensity of exercise undertaken. The differences in 24-hour glycaemic measures in response to
the two exercise protocols may also have been related to potential changes substrate utilisation
and sympathetic/parasympathetic balance, with respect to changes in metabolic gas exchange
and heart rate variability measures observed during discontinuous exercise and within the
recovery period.
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5.1 Acute changes with exercise
5.1.1 Blood glucose changes in pregnant women
Acute exercise-related blood glucose responses in pregnant women have been linked to the
exercise intensity and duration (Artal, Platt et al. 1981, Bonen, Campagna et al. 1992, Davenport,
Mottola et al. 2008, Ruchat, Davenport et al. 2012). Fifteen minutes of light treadmill walking in
the third trimester has been shown to maintain blood glucose levels (Artal, Platt et al. 1981).
However, moderate exercise intensity for a 30-minute period resulted in blood glucose declining
by approximately 25% in the second trimester, and 31% in the third trimester. The non-pregnant
control group recording only a 15% reduction over the same bout of exercise (Bonen, Campagna
et al. 1992). The present study demonstrated that a bout of discontinuous exercise at moderate
intensity and a bout of continuous exercise at lower intensity produced different results for blood
glucose changes over time, when undertaken by pregnant women compared with non-pregnant
women. This difference occurred despite the continuous and discontinuous exercise protocols
being matched for total work (energy expenditure). Importantly, for pregnant women both types
of exercise had positive effects on acutely reducing blood glucose. This was not the case for nonpregnant women, where only continuous exercise led to significant blood glucose reductions in
the short term (15-minutes post-exercise). The responses observed in pregnant women following
30 minutes of light intensity exercise showed that a reduction of acute blood glucose could be
achieved at a lower intensity than previously reported by Bonen, Campagna et al. (1992).
Furthermore, exercise performed in a discontinuous structure at moderate intensity, which only
involved a total of 15 minutes of work (and 15 minutes of rest) also led to significant reduction of
acute blood glucose. Artal, Platt et al. (1981) found no change in blood glucose following 15minutes of continuous, light exercise. Thus, the observations of the present study support that for
exercise bouts of shorter duration, intensity is likely an important variable for inducing acute
glycaemic changes in pregnant women.

Despite this study being a pilot study, it was interesting to observe that in just this small cohort of
pregnant women (n = 7) with blood glucose measures within the normal ranges, both continuous
and discontinuous protocols were able to result in positive reductions of acute blood glucose
levels. Given that large individual variations in blood glucose levels are normal, a larger sample
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size and ability to include participants with blood glucose levels above the normal ranges would
have been more effective at showing acute and 24-hour blood glucose changes in both pregnant
and non-pregnant women. Irrespective of the continuity of the exercise protocol, this
investigation observed a significant reduction in acute blood glucose levels in pregnant women at
exercise intensities and duration (of work) that were lower than that previously reported (Artal,
Platt et al. 1981, Bonen, Campagna et al. 1992).

Greater blood glucose reductions following acute exercise in pregnant women compared to nonpregnant have been previously attributed to alterations in the pathways of glycogenolysis and
gluconeogenesis in pregnancy (Lotgering, Spinnewijn et al. 1998, Bessinger, McMurray et al.
2002). A recent study reported that after 20 minutes of steady-state exercise (vigorous intensity),
similar rates of plasma glucose reduction were observed for pregnant (34-38 weeks) and nonpregnant women, matched for physical activity background, while after 40 minutes, glucose
concentrations in non-pregnant women had significantly increased but were almost unchanged
in pregnant women (Mottola, Inglis et al. 2013). The current study also observed that continuous
exercise had similar effects for reducing blood glucose in pregnant and non-pregnant women.
Yet, there were differences between the two groups following the discontinuous exercise, with a
significant effect found for pregnant women only. As pregnancy is a condition of progressive
insulin resistance, it is associated with higher levels of circulating insulin (Bonen, Campagna et
al. 1992, Bessinger, McMurray et al. 2002). Bonen, Campagna et al. (1992) suggested that while
pregnancy-related insulin resistance was acutely reduced by exercise (via the effect of exerciseenhanced insulin sensitivity), overall insulin levels present during exercise in pregnant women
remained higher than those of non-pregnant women. Indeed, Mottola, Inglis et al. (2013) also
reported plasma insulin to be twice as high in pregnant compared to non-pregnant women
throughout the exercise bout. Early research shows insulin to be inhibitory to glycogenolysis, and
potentially to gluconeogenesis (Felig and Wahren 1971), meaning that higher circulating insulin
levels in pregnant women may contribute to the impaired or delayed hepatic glucose production
in response to glycogen depletion, as suggested by Bessinger, McMurray et al. (2003). Thus, the
differences observed in the present study between pregnant women and non-pregnant women
may relate to enhanced glucose uptake stimulated by exercise, but also to altered hepatic glucose
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production in response to glycogen depletion of exercise. Furthermore, a higher level of
circulating insulin during exercise in pregnant women (compared to non-pregnant) would allow
for a greater degree of exercise stimulated insulin-dependent mechanisms of glucose uptake.

With respect to exercise intensity and pregnancy, a study of acute exercise effects in women with
gestational diabetes found that moderate-intensity exercise had a greater effect on reducing acute
blood glucose levels compared to low intensity exercise (Avery and Walker 2001). The current
study is not directly comparable as the participants were found to have normal blood glucose
levels over the course of the study, despite the pregnancy group including women with
diagnosed GDM, or with risk factors for abnormal glucose tolerance (high BMI pre-pregnancy,
inactive). However, in the current study, both discontinuous and continuous exercise protocols
had similar effects on reducing acute post-exercise blood glucose in pregnant women. Novel
differences in the current study were the discontinuous structure of the moderate intensity bout,
which mean only 15 minutes of total exercise were undertaken to elicit blood glucose reductions
(compared to 30-minutes in the earlier study), and the matched total work (energy expenditure)
between protocols. Previous studies in type 2 diabetes have suggested that energy expenditure is
the key variable for post-exercise effects on blood glucose (Larsen, Dela et al. 1999). As total work
was not controlled in the Avery and Walker study (2001); the reductions in blood glucose
observed post-exercise may have not been related only to exercise intensity but also to differences
in energy expenditure between the two exercise trials. Both trials were performed for 30 minutes,
and at a relatively higher intensity than the current study.

When total work is controlled, it has been observed that low (40%VO2peak) and high (80%VO2peak)
intensity bouts of exercise both led to similar increases in skeletal muscle GLUT4 mRNA and
GLUT4 protein in healthy individuals (Kraniou, Cameron-Smith et al. 2006). As the primary
glucose transporter protein for skeletal muscle tissue, similar increases in GLUT4 synthesis
would have likely increased both insulin-mediated and contraction-driven glucose uptake
during exercise (Zisman, Peroni et al. 2000, Kraniou, Cameron-Smith et al. 2006). In the current
study, the total work output performed was equal for the discontinuous and continuous exercise;
therefore, post-exercise blood glucose changes were not attributable to obvious differences in
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exercise energy expenditure between the protocols. Rather, overall energy expenditure may have
been lower than required to elicit significant and sustained blood glucose reductions in shortterm post-exercise period.

In the current study, participants from both the pregnant group (3 out of 7) and the non-pregnant
group (5 out of 7) were classified as above the healthy weight range by BMI (pre-pregnancy). BMI
itself was not significantly different between groups (26.14 kg.m-2 compared to 24.63 kg.m-2
respectively); however, the standard deviation of the pregnancy group (SD 6.31), with two
participants categorised as obese or morbidly obese, was more than double that of the nonpregnant group (SD 2.749). Perhaps unexpectedly, the GDM women in the pregnancy group
were all within healthy weight range according to BMI classification. Both groups also had
similar baseline blood glucose levels, which (other than the fasting levels for GDM), were within
clinical target ranges of optimal glycaemic control (Inzucchi, Bergenstal et al. 2012, Nankervis,
McIntyre et al. 2013). Therefore, having women with an obese BMI prior to pregnancy, as well as
women with GDM in the pregnant group means this group may represent higher underlying
levels of skeletal muscle insulin resistance and glycaemic dysfunction than would be normally
associated with general pregnancy (Leturque, Burnol et al. 1984, Kuhl 1991, Sorenson and Brelje
1997, Barbour, McCurdy et al. 2007, Colomiere, Permezel et al. 2010). Nevertheless, it is still
clinically important that there were significant effects of both exercise protocols on post-exercise
blood glucose levels in this pregnant group.

5.1.2 Metabolic exercise response
The current study found no interaction between maternal status and exercise protocol
(continuous vs. discontinuous) on exercise oxygen consumption. This result supports previous
studies, where no difference was observed in submaximal oxygen consumption between
pregnant and non-pregnant women, suggesting that pregnancy alone does not significantly
increase metabolic demands during mild or moderate intensity exercise (Guzman and Caplan
1970, Lotgering, Gilbert et al. 1985, Sady, Carpenter et al. 1989, Jaque-Fortunato, Wiswell et al.
1996, Avery, Wolfe et al. 2001). Metabolic demands increase with progressing gestation during
weight-bearing exercise (e.g. treadmill walking), but remains relatively unaffected by pregnancy
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during weight-supported modes, for example cycling, where metabolic demand is independent
of body weight (Artal, Masaki et al. 1990, Carpenter, Sady et al. 1990, Pivarnik, Lee et al. 1991). In
the current study where cycling was the selected exercise mode, gestational stage of pregnant
participants did vary from the start to the end of the second trimester, yet there was no difference
in exercising oxygen consumption, relative to maternal condition. Therefore, the results support
the previous studies discussed earlier that the exercise mode of semi-recumbent cycling does not
affect exercising metabolic demands differently for pregnant women compared with nonpregnant women and offers a practical exercise choice for women to engage in regular or daily
exercise while avoiding the weight-bearing effects of higher metabolic costs of exercise with
progressive gestation.

Similarly, no interactions were observed in the exercising minute ventilation between exercise
protocol and pregnancy status. This finding is in line with earlier research showing that minute
ventilation during exercise was not different in pregnant participants compared to non-pregnant
controls (Lotgering, Spinnewijn et al. 1998, Avery, Wolfe et al. 2001), but contrasts an earlier
study that reported minute ventilation as significantly higher during submaximal exercise in
pregnant women compared to non-pregnant women (Jaque-Fortunato, Wiswell et al. 1996).
There was also no interaction observed in the respiratory exchange ratio between exercise
protocol and pregnancy status. As a relative measure of fat compared to carbohydrate substrate
utilisation, the finding of a similar exercising respiratory exchange ratio between pregnant and
non-pregnant women suggests that substrate utilisation did not differ between the two protocols
relative to pregnancy condition.This supports earlier literature that found no difference in
respiratory exchange ratio during exercise in pregnancy, compared to non-pregnant condition
(Jaque-Fortunato, Wiswell et al. 1996, Bessinger, McMurray et al. 2002).

As there was no interaction between pregnancy status and exercise protocol type on oxygen
consumption, respiratory exchange ratio or minute ventilation, the data of pregnant and nonpregnant participants were combined to enable a direct comparison between the continuous and
discontinuous protocols, without the primary variable of pregnancy. From this, there was no
significant difference in exercising oxygen consumption found between the exercise protocols,
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which showed that total work (representing exercise energy expenditure) was shown to be well
controlled and equal between the protocols; a planned outcome of the adopted research design.
The pooled analysis found a significantly higher respiratory exchange ratio during discontinuous
exercise compared to continuous exercise, which reflects greater carbohydrate substrate
utilisation during the discontinuous bout. A recent study also demonstrated significantly greater
respiratory exchange ratio in the immediate post-exercise recovery (0 - 5 minutes) following 10
minutes of high intensity interval training compared with 30 minutes of moderate intensity,
continuous cycling (Metcalfe, Koumanov et al. 2015). In the current study, the exercise intensity
was significantly lower than has been researched in traditional high intensity interval training.
Furthermore, the work to rest intervals of 2 ½ minutes used in the current investigation were
longer than well-established high intensity interval protocols that usually incorporate intervals of
one minute or less (Gibala, Little et al. 2006, Burgomaster, Howarth et al. 2008, Gillen, Little et al.
2012). Intervals of moderate intensity were chosen to be appropriate for pregnant women not
regularly exercising, or with a background of cardiometabolic risks including physical inactivity,
obesity and gestational diabetes mellitus (Davenport, Charlesworth et al. 2008, Hayman, Brown
et al. 2016).

Despite the relatively lower intensity compared to the existing literature, the

combination of discontinuous periods of moderate intensity exercise used in the present study
was enough to elicit a significant shift from baseline (towards higher carbohydrate metabolism.

5.1.3 Sympathetic and parasympathetic modulation during exercise
Metabolic dysfunction that occurs with obesity and diabetes is associated with increased
sympathetic activity and reduced heart rate variability (HRV) (Singh, Larson et al. 2000, Maser,
Lenhard et al. 2014). Healthy pregnancy without any glycaemic dysfunction (beyond the natural
biological progression in insulin resistance with advancing gestation) is also associated with
changes in autonomic control, with a shift towards relatively greater sympathetic modulation
and lower parasympathetic control at rest (Ekholm, Hartiala et al. 1997, Maser, Lenhard et al.
2014, May, Knowlton et al. 2016). During exercise, the current study found significant differences
in pregnant and non-pregnant women for the effects of the type of exercise (continuous vs.
discontinuous) on HRV measures associate with sympathetic and parasympathetic modulation.
A significant interaction of maternal condition and protocol type was observed during exercise
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for RMSSD, which was found to be higher by 38.1% in non-pregnant women during continuous
exercise compared to pregnant women. Yet during discontinuous exercise, RMSSD was higher by
25.2% in pregnant women than non-pregnant women. As a time domain measure of beat-to-beat
variance during exercise, RMSSD is used to estimate vagal-mediated changes in HRV, and is
correlated with the high frequency (HF) power spectral component associated with
parasympathetic modulation, and related to respiration activity (Electrophysiology 1996, Shaffer,
McCraty et al. 2014).

No significant changes were observed in HF power measures relative to pregnancy and protocol,
but there was a significant interaction observed for low frequency (LF) power. LF power was
significantly higher in non-pregnant women compared to pregnant women during continuous
exercise, but for discontinuous exercise, it was higher in pregnant women compared to nonpregnant women. The interpretation of LF power is controversial in the literature, in terms of
whether it is a marker of both sympathetic modulation and vagal activity or sympathetic
modulation only; and in relation to how

measurement conditions (such as resting vs.

ambulatory; normal breathing vs. paced breathing) impact this interpretation (Shaffer, McCraty
et al. 2014).

The results of the current study show that RMSSD differences between pregnant and nonpregnant women suggesting higher vagal activity in non-pregnant women compared to pregnant
women during continuous exercise, yet higher vagal activity for pregnant women during
discontinuous exercise (compared to non-pregnant). In contrast, the higher LF observed for nonpregnant women during continuous exercise may indicate relatively higher sympathetic
modulation than for pregnant women doing the same exercise. However, the opposite was
observed for discontinuous exercise, with a higher LF in pregnant women compared to nonpregnant women. It is challenging to confirm exact differences between protocols based on
pregnancy, due to the uncertainty of what LF power measures truly represents in this study.
Furthermore, there is a scarcity of literature on gestational HRV responses during exercise to be
able to draw on for comparison or clarity. Just one study was found to report on autonomic
changes in pregnant women under acute exercising conditions (Avery, Wolfe et al. 2001), which
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found that the increased sympathetic modulation during exercise was similar for pregnant and
non-pregnant women, but that pregnant women had relatively less reduction of parasympathetic
output. This was attributed to their already lowered parasympathetic modulation at rest.
Therefore, the differences observed between groups during exercise in the present study may
reflect the underlying differences in resting HRV between pregnant and non-pregnant women.

In healthy populations, relative changes in sympathetic and parasympathetic modulation and
overall spectral power during exercise are influenced by the exercise intensity, with higher
intensities associated with greater reduction in individual spectral power measures and total
power, driven by relative sympathetic domination over vagal parasympathetic output (Robinson,
Epstein et al. 1966, Perini and Veicsteinas 2003, White and Raven 2014). When the data of nonpregnant and pregnant participants were pooled for more robust comparisons between the two
protocols performed at different exercise intensities, this revealed significant effects for some of
the frequency domain measures. Continuous exercise was associated with higher LF for peak and
relative measures of power, as well as higher relative HF power; while discontinuous exercise
resulted in higher absolute LF power and greater LF/HF ratio. The interpretation of LF measures
alone are not agreed on in the current literature, and LF/HF ratio is also one that can be
misinterpreted in isolation, particularly from short-term recordings such as those used in this
study (Electrophysiology 1996, Shaffer, McCraty et al. 2014). However, it has been suggested that
under conditions where increased effort and greater sympathetic nervous system activation are
present, such as during exercise, that a high LF/HF ratio (when also considered with individual
HF and LF power) is indicative of greater sympathetic activity, relative to parasympathetic
activity, (Shaffer, McCraty et al. 2014). It is interesting then to consider the findings of the current
study discussed earlier where RMSSD, as a marker for vagal drive and associated with HF
(parasympathetic modulation), was relatively higher in pregnant women (compared to nonpregnant women) during the moderate intensity, discontinuous exercise. This response could
reflect the higher sympathetic input associated with the pregnant condition at baseline resting
conditions.
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Lastly, the current study observed that overall heart rate variability, as represented by the timedomain measure of SDNN, was significantly higher during discontinuous exercise compared to
continuous exercise. Thus, the differences between the two protocols in the current study suggest
discontinuous exercise had a relatively higher degree of sympathetic modulation (compared to
parasympathetic) modulation. This may be reflective of the relatively higher exercise intensity
(moderate vs. light) performed during this protocol. Higher exercise intensities are associated
with a greater reduction in total power, as well as individual spectral power (Perini, Orizio et al.
1990, White and Raven 2014). In the current study, the relatively higher intensity of the exercise
intervals during discontinuous protocol (compared to the continuous protocol) may have been
offset by the interval structure that also included intervals of total rest. Therefore, the greater
reduction in total power observed than what would be expected with moderate intensity
compared to low intensity exercise may have been less than if the moderate intensity exercise
was performed in a continuous structure.

The overall HRV findings of the current study give some preliminary new insights into acute
exercise HRV responses in pregnant women, which may warrant further investigation of
potential differences in sympathetic and parasympathetic modulation during discontinuous, or
interval, structured exercise compared with continuous exercise, and responses observed in
pregnant and non-pregnant women However, there is also likely to be an impact of underlying
baseline sympathetic modulation of pregnancy on the observed differences in exercising HRV
responses between pregnant and non-pregnant groups. Additionally, the direct comparison of
the two protocols with the participants’ pooled show that a higher level of sympathetic
modulation found during discontinuous exercise may be related to the higher intensity
performed, rather than the difference in structure/continuity of exercise workload.
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5.1.4 Acute exercise recovery
5.1.4.1 Post-prandial blood glucose
Exercise energy expenditure, rather than intensity, has been reported as the key variable for
affecting glycaemic changes post-exercise (Larsen, Dela et al. 1997, Larsen, Dela et al. 1999). In the
present study, post-prandial blood glucose response to a standardised snack was compared
between a control condition (no exercise) on Day 1 and a post-exercise condition on Day 2, where
a snack was consumed 15-minutes after exercise. No interaction was observed between the
protocols over time for 1-hour post-prandial responses, in either pregnant or non-pregnant
women. A previous study by Mottola, Wies et al. (1998) also reported no differences in postprandial response in pregnant women compared to baseline, when given a high glucose load
(75g oral glucose tolerance test) after 20 minutes of mild (30% VO2peak) cycling. Although the
serve of carbohydrate provided in the current study was much less (13g); the exercise bouts
undertaken were not dissimilar, considering the protocols of the current study: 30 minutes of
continuous cycling performed at a workload for 25% VO2peak predicted, and the discontinuous
protocol being matched for total work.

Based on the normal blood glucose levels across both groups, when participant groups were
pooled to compare the two exercise protocols directly, without the primary variable of
pregnancy, there was a significant blunting of 1-hour post-prandial BGL on Day 2 compared to
Day 1, for each protocol. Following continuous and discontinuous exercise respectively, 1-hour
post-prandial BGL was lowered by 16.9% (from 6.650 mmol.L-1 on Day 1 to 5.521 mmol.L-1 on
Day 2) and 10.7% (from 6.557 mmol.L-1 on Day 1 to 5.850 mmol.L-1 on Day 2). A recent review on
the influence of the timing and intensity of exercise on post-prandial levels concluded that
aerobic exercise performed after a meal was more effective than exercise before a meal in both
healthy and diabetic adults (Haxhi, Scotto di Palumbo et al. 2013). The exercise in the current
study was performed pre-prandial, thus it was interesting to find both protocols were effective at
significantly blunting post-prandial blood glucose. This suggests that undertaking exercise prior
to a meal may have the potential to also be an effective strategy in blunting post-prandial BGL,
however further research is needed in this area for any conclusive or specific recommendations.
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5.1.4.2 Recovery metabolic responses
In the current study, no interaction was observed between pregnancy condition and exercise
protocol on measures of recovery oxygen consumption (also known as post-exercise oxygen
consumption, EPOC), respiratory exchange ratio or minute ventilation. Furthermore, no
significant differences in the effects of each protocol were found when participants were pooled.
However, when compared with baseline resting measures, both oxygen consumption and minute
ventilation remained significantly elevated during the recovery period of the continuous, low
intensity protocol but not the discontinuous, moderate intensity protocol. This contradicts
previous literature that found exercise intensity to be the major determinant for EPOC, with
higher intensities producing larger EPOC levels (Gore and Withers 1990, Larsen, Welde et al.
2014), but supports a more recent high intensity interval study that found no difference in EPOC
levels relative to exercise intensity (Metcalfe, Koumanov et al. 2015).

Different exercise intensities in the current study did not produce differences in recovery
respiratory exchange ratio, and comparison against baseline levels showed that both intensities
led to significantly higher recovery oxygen consumption and suggesting that each protocol
resulted in continued higher carbohydrate metabolism in short-term recovery. This is similar to
an earlier study, where a bout of moderate intensity, continuous cycling did not produce
different EPOC levels to a bout of high-intensity interval cycling with matched total work and
duration (McGarvey, Jones et al. 2005).

5.1.4.3 Recovery HRV responses
There was no difference found in the HRV measures during exercise recovery, either related to
interactions of pregnancy condition and protocol type, or between protocols. Earlier literature
has shown that following low intensity exercise, autonomic control of HRV returns to baseline
conditions within 5 minutes, with a dose-response of longer HRV changes related to higher
exercise intensities (Perini, Orizio et al. 1990, Terziotti, Schena et al. 2001). Mourat, Bouhaddi et
al (2004) compared effects of a single bout of each of continuous and interval exercise on HRV,
and found during the first hour following interval exercise, there were greater decreases in total
power and HF values, suggestive of a slower return of baseline parasympathetic (vagal) activity
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than after continuous exercise (Mourot, Bouhaddi et al. 2004). The investigation of recovery HRV
differences between protocols in the current study may have also been limited by the chosen
timing of the five-minute segment used for analysis. This was captured between minutes 2-7 of
the 10-minute recovery phase. In contrast, a study that also used short-segment HRV for
comparing exercise recovery following acute exercise of low, moderate and high intensities
reported significant differences were mainly observed within the first minute (Michael, Jay et al.
2016). Therefore, the chosen time to capture recovery HRV measures in the current study is a
likely limitation of being able to observe differences for HRV responses post-exercise, particularly
given the lower exercise intensities used. Nevertheless, this adds a starting place to the literature
in this field for future research, as no study has reported on recovery HRV measures in pregnant
women following an acute bout of exercise.

5.2 Glycaemic control over 24 hours
5.2.1 Daily blood glucose variability
No significant interaction was observed between maternal condition and time for exercise effect
on 24-hour mean blood glucose level and variability, for either continuous or discontinuous
exercise. A recent meta-analysis of studies that used continuous glucose monitoring in type 2
diabetes concluded that acute exercise significantly decreased average daily blood glucose
concentrations and time spent in hyperglycaemia range, with no effect on fasting or time in
hypoglycaemia (MacLeod, Terada et al. 2013). Two of the studies included had also investigated
glucose variability. One found no effect (Praet, Manders et al. 2006), while the other observed
that variability was reduced following a single bout of moderate intensity exercise (Van Dijk,
Manders et al. 2013). In contrast to a large volume of studies in type 2 diabetes; there have been
no previous investigations either in general pregnancy or GDM women using continuous glucose
monitoring to determine acute exercise effects on 24-hour glycaemic control. Although results of
the current study provide a novel contribution to this area, the observations were found in
women with a relatively normal baseline of glycaemic control (including those with GDM), based
on the clinical glycaemic target values for gestational diabetes and type 2 diabetes (Inzucchi,
Bergenstal et al. 2012, Nankervis, McIntyre et al. 2013). Thus, it would be important to repeat a
similar investigation in GDM women who have greater dysfunction in glycaemic control (overall,
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or for specific post-prandial responses) to determine whether exercise effects on 24-hour blood
glucose control are different when baseline glycaemia is not optimal during pregnancy.

When the data from both groups were pooled in the current study to directly compare the
exercise protocols, there were significant changes in 24-hour blood glucose levels and variability
for the two exercise protocols. The mean 24-hour blood glucose level was significantly higher
(5.64 mmol.L-1) the day after discontinuous, moderate intensity exercise was undertaken,
compared with the baseline day of no exercise (5.39 mmol.L-1). This was unexpected given the
opposite effects previously reported in type 2 diabetes, which found a single bout of exercise
lowered 24-hour blood glucose levels (Van Dijk, Manders et al. 2013). Interestingly, a bout of lowintensity cycling significantly reduced 24-hour blood glucose level, whereas the higher intensity
bout of cycling of equivalent total work had no effect (Manders, Van Dijk et al. 2010). In the
current study, mean 24-hour blood glucose increased after discontinuous exercise, whereas
continuous, low intensity protocol did not have any effect. It could be hypothesised that the
difference in the direction of effect may be related to the difference in the baseline levels of
glycaemic control between the type 2 diabetes cohort, and the women in the current study, where
both pregnant and non-pregnant women had blood glucose levels within the normal range for
optimal glycaemic control.

The standard deviation of all 24-hour blood glucose level was significantly lower following both
continuous (16.5%) and discontinuous (19%) exercise, compared to Day 1 baseline. However, the
24-hour blood glucose level coefficient of variation was only reduced following discontinuous
exercise. Additionally, discontinuous exercise was associated with higher mean blood glucose
level overnight, and again with reduced variability, whereas there were no changes in overnight
mean blood glucose level or variation following continuous exercise. Interestingly, both
continuous and discontinuous exercise was observed to elicit higher recorded overnight
minimum glucose levels, when compared to the minimum blood glucose level during the
baseline night preceding each bout of exercise. Our findings contradict those of Bacchi, Negri et
al. (2012) who reported that nocturnal glucose levels in individuals with type 2 diabetes were
significantly lower following aerobic exercise compared with the previous day of no exercise.
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Again, this discrepancy may in part be explained by the difference in baseline glycaemic
measures between the type 2 diabetes study and the current study. Regardless, looking more
broadly at the results of the current investigation, exercise intensity may be an important factor
for reducing the variability of blood glucose concentrations following an acute exercise bout,
when the findings of a reduction in 24-hour blood glucose variability following discontinuous,
moderate intensity exercise but no difference in variability following continuous, low intensity
exercise are considered together.

5.2.2 Post-prandial blood glucose response
Post-prandial hyperglycaemia is a clinical risk factor for cardiovascular complications (Stratton,
Adler et al. 2000). In pregnancy, lower post-prandial blood glucose levels have been associated
with fewer perinatal complications (Jacqueminet and Jannot-Lamotte 2010). In the current study,
a single bout of continuous or discontinuous exercise both significantly blunted post-prandial
blood glucose responses to a snack consumed shortly after exercise. However, there was no
prolonged exercise effect on post-prandial BGL for a main meal consumed between 10 – 16 hours
after exercise for either pregnant or non-pregnant women. The women in the current study had
post-prandial blood glucose responses that fell within the clinical range for optimal glycaemic
control in type 2 diabetes, as well as the lower target range for pregnancy [1-hr post-prandial
<7.4mmol.L-1; 2hr <6.7 mmol.L-1] (Inzucchi, Bergenstal et al. 2012, Sullivan, Umans et al. 2012,
Nankervis, McIntyre et al. 2013). Having groups with normal post-prandial responses may have
limited the potential effect for any exercise-related prolonged changes.

In a study of women with GDM who had dysfunctional glycaemic control, a 30-minute bout of
moderate intensity (60%VO2max) cycling did not have any observed effect on next-day breakfast
post-prandial response (Lesser, Gruppuso et al. 1996). In contrast, a type 2 diabetes study showed
prolonged exercise effects in the 24 hours following exercise, with of significant lowering of postprandial blood glucose reduction following a 60-minute bout of moderate intensity (60% HRR)
cycling (Oberlin, Mikus et al. 2014). The contrast in the responses observed between these two
studies may be related to the pregnancy condition, the overall duration of the exercise (which
was doubled in the latter study), or a combination. Looking at the effects of exercise structure,
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Little, Jung et al. (2014) found that a single bout of high-intensity interval exercise, compared to
moderate intensity continuous training of matched work, had a greater effect on improving postprandial glycaemia over the following 24-hours (Little, Jung et al. 2014). This contrasts with
Larsen, Dela et al. (1999) who found that it was the total energy expenditure, and not intensity,
that was the key variable for exercise effect on post-prandial glucose responses in type 2 diabetes
(Larsen, Dela et al. 1999). In the current study, the energy requirements of the exercise protocols,
as a factor of the relative intensities and the durations, would be considerably less than the
requirements for the exercise utilised undertaken in the study by Little, Jung et al (2014). This
may have been a limiting factor preventing observation of any post-prandial responses beyond
the acute exercise period, in either pregnant or non-pregnant women.

5.2.3 Fasting blood glucose
As was found for the post-prandial BGL responses, a single bout of continuous or discontinuous
exercise had no significant effect on the fasting blood glucose measures captured the morning
after exercise, compared to baseline fasting blood glucose levels. Pregnant condition also had no
interaction with changes in fasting blood glucose levels between baseline and post-exercise. Early
studies in GDM women failed to demonstrate any change in fasting blood glucose following a
single bout of light or moderate intensity exercise (Lesser, Gruppuso et al. 1996, Avery and
Walker 2001). Similarly, a short-term exercise study found that seven consecutive days of aerobic
exercise training had no effect on fasting blood glucose levels in overweight or obese, sedentary
adults with type 2 diabetes under free-living conditions (Mikus, Oberlin et al. 2012).
Furthermore, after the completion of a 20-week exercise training program in healthy but
sedentary participants, a single bout of exercise was found to increase fasting glucose levels, as
well as decrease fasting insulin levels in the 24-hours following exercise (Boulé, Weisnagel et al.
2005). Thus, the potential for acute exercise to have a significant effect on fasting blood glucose
levels in healthy or metabolic dysfunction populations has not yet been well established
(MacLeod, Terada et al. 2013). Therefore, for pregnant women who may have difficulty with their
fasting blood glucose levels but otherwise maintain good glycaemic control, a bout of exercise
may not be an effective strategy for improving fasting levels in pregnancy.
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In Australia, the fasting blood glucose level during pregnancy for diagnosis of GDM is >5.1
mmol.L-1. Fasting for diagnostic purposes is done through a set protocol and measured from
venous blood obtained through a medically-referred blood test. However, women are also
required to self-monitor their fasting blood glucose levels, which is done using a glucometer and
captures capillary blood glucose. For self-monitoring, fasting blood glucose is required to be <5.0
mmol.L-1as an indicator of good glycaemic control (Coustan, Lowe et al. 2010, Nankervis,
McIntyre et al. 2013). Changes in GDM treatment, such as an indication to commence or increase
insulin therapy, are often based on the self-measured blood glucose records, therefore there is
some validity in comparing fasting levels from this study to those used to evaluate fasting levels
in GDM. The current study found no carry-over effects from the acute exercise effect on fasting
blood glucose levels for either group. Interestingly, the current study found that the mean fasting
BGL in non-pregnant women after continuous exercise (4.84 mmol.L-1) was the only measure that
would meet the clinical threshold criteria (<5.1mmol.L-1) for appropriate fasting blood glucose
control in pregnancy. Furthermore, the mean Day 1 fasting blood glucose levels, as measured by
CGM, in non-pregnant participants (5.19 mmol.L-1 in Phase 2, and 5.39 mmol.L-1 in Phase 3) were
also above the optimal glycaemic control threshold criteria used in pregnancy.

It is not clear whether the observed changes in overnight blood glucose in the current study had
any direct interaction with fasting blood glucose levels the following morning. Following each
protocol, the minimum blood glucose level recorded overnight on Day 2 was higher than during
the Day 1 overnight period. After discontinuous exercise specifically, mean blood glucose
overnight was also significantly higher than on Day 1. This is an area that would benefit from
further investigation using more precise measurement of fasting blood glucose in pregnant
women, including those diagnosed with gestational diabetes. If there was an association between
exercise performed during the day and increases in overnight blood glucose with an effect on
fasting blood glucose the following morning, there would be important practical implications for
women who exercise regularly during pregnancy, and the clinical threshold level for fasting
levels in the diagnostic criteria for GDM in Australia.
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5.3 Perception of exercise exertion and enjoyment
The perceived physical exertion during either of the protocols was not affected by pregnancy;
however, when groups were pooled, the RPE scores for overall exertion and for specific effort of
the legs were both significantly higher during the discontinuous protocol, despite an equivalent
metabolic cost between each exercise bout. This finding mirrors that found with high-intensity
interval exercise in obese adults, where Little, Jung et al. (2014) observed RPE to be higher during
high intensity interval exercise, compared with continuous moderate intensity exercise (Little,
Jung et al. 2014). In contrast, a study of obese women with and without type 2 diabetes found
RPE to be higher for continuous exercise compared with intermittent exercise bouts (reasonably
matched for total work and duration) (Coquart, Lemaire et al. 2008). In that study, RPE was
significantly lower during intermittent higher intensity exercise, than during continuous exercise
of lower intensity. The authors related this to the concept of perceptual preference, where the
lowest RPE was associated with the exercise conditions that were perceptually preferred by
participants (Robertson and Noble 1997). The qualitative findings of the current study appear to
contradict this finding. Although RPE was higher for discontinuous exercise, the majority of
participants (12/14) also enjoyed the experience of the discontinuous protocol over the
continuous protocol, which may be a reflection on previous findings that individuals are more
likely to select an exercise intensity that corresponds with an RPE level between 10 – 14, as this
range (light-moderate intensity) has been associated with a positive affective, or mood, response
(Ekkekakis 2009).

Furthermore, when participants in the current study were asked at the end of their trial to
qualitatively compare the relative difficulty of the two protocols, the responses were quite mixed.
Just over half (8/14 participants) reported finding the discontinuous protocol either mildly (4) or
moderately (4) more difficult, while more than a third felt there wasn’t a difference between the
two (4/14). The remaining two participants found the continuous protocol moderately more
difficult. These were both from the pregnancy group and identified that their breathing and
overall fatigue levels were more noticeable during the continuous work without rest. Therefore,
despite significantly higher reported levels of perceived exertion during the discontinuous
exercise, the perception of comparative difficulty between the protocols was more mixed
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suggesting a variety of inputs are evaluated by individuals when it comes to exercise preferences
(Duncombe, Wertheim et al. 2009, Evenson and Bradley 2010). From a clinical perspective, this
has encouraging implications for exercise compliance. As observed in this study, a bout of
discontinuous, moderate intensity exercise had significant and positive effects on acute blood
glucose and 24-hour glycaemic variability and was perceived as requiring greater effort, and yet
was perceived to be more enjoyable by pregnant and non-pregnant women with widely varying
levels of fitness, physical activity and weight.

5.4 Resting measures
5.4.1 Baseline glycaemic control
Pregnant and non-pregnant women did not have significantly different baseline 24-hour blood
glucose control. Furthermore, both groups in the study had relatively normal glycaemic levels
compared with reference values for optimal glycaemic control, except that mean and peak
fasting measures for the pregnant group (normoglycaemic and GDM women combined) were
higher than the clinical threshold for GDM (Coustan, Lowe et al. 2010, Hernandez, Friedman et
al. 2011, Nankervis, McIntyre et al. 2013). While the similarity of blood glucose measures between
groups at baseline allowed for appropriate comparison of exercise effects on measures of
glycaemic control, the actual effect of the exercise may have been less than what would be
observed in women with less optimal glycaemic control. It also limits the extrapolation of results
here to women with gestational diabetes or overt diabetes in pregnancy.

5.4.2 Baseline metabolic measures
Resting metabolic measures prior to exercise showed no differences in baseline oxygen
consumption, respiratory exchange ratio or minute ventilation related to the interaction of
pregnancy condition and protocol type. Similarly, when the two groups of participants were
pooled, no difference was found in resting metabolic measures between the two protocols,
therefore importantly demonstrating a similar baseline metabolic rate between the conditions of
the study.
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5.4.3 Resting heart rate variability
In pregnancy, there is a greater bias toward sympathetic modulation in response to demonstrated
cardiovascular and metabolic adaptions associated with a normal pregnancy (Ekholm, Hartiala et
al. 1997, Avery, Wolfe et al. 2001). The significantly lower pNN50 and RMSSD measures in the
pregnant women at baseline for the current study align with relatively lower parasympathetic
control. In addition, higher resting heart rate and shorter time between QRS intervals of beats
(mean R-R interval) were observed in the pregnant women, further indicating higher resting
sympathetic input. As an index of overall HRV, resting SDNN might also have been expected to
be reduced in pregnant women. This comparison almost reached significance in the current
study (P= 0.0573), with a trend for lower SDDN in pregnant (32.80ms) compared to non-pregnant
(64.91ms) women. Thus, the differences in resting HRV measures observed in the current study
between pregnant and non-pregnant women reflect the well-established autonomic changes with
pregnancy.

5.5 Study Limitations
Initially, the aim of this study was to compare three groups of women: i) pregnant with
normoglycaemic control, ii) pregnant with diagnosed gestational diabetes (GDM), and iii) notpregnant, with no known glycaemic dysfunction. Difficulties in recruiting women for both the
healthy pregnancy and GDM groups led to participants in these two groups eventually being
combined. This decision was made as it had been identified that the blood glucose levels for the
GDM women who had participated in the study were within normal ranges (other than their
diagnosed fasting BGL) throughout the study period. With the primary focus of the study being
blood glucose responses to exercise, neither the glycaemic target ranges nor the exercise
recommendations differ for GDM pregnancy compared to general pregnancy, thus this was not
considered to be a limiting factor to changing the study groups. However, it did mean that some
of the original design factors and the power calculation of the sample size and primary variable
were no longer valid or ideal, and this has led to some challenges in justifying some areas within
the current context of the study.
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It is also recognised that the small sample size in combination with the normal propensity for
large individual variation in blood glucose levels limits the strength and the applicability of the
findings of the current study, particularly with respect to observing differences in glycaemic
responses between pregnant and non-pregnant women. Furthermore, the fact that baseline
glycaemic measures were normal in both groups may also have blunted or changed the exercise
effects observed, in terms of the degree and/or direction of change.

The use of continuous glucose monitoring data, while novel for application of investigating
exercise effects on glycaemic control in pregnancy, is not as accurate as direct measures of
dysfunctional glycaemic control in pregnancy, such as blood tests for fasting levels in pregnancy.
This study also did not measure insulin resistance, which would have added greater insight into
underlying abnormal glycaemic control. As a pilot study, measuring insulin resistance was
considered too invasive and not necessary for the current design. It is also a measure more likely
to be affected by chronic exercise training, rather than a single bout of acute exercise.
Additionally, the normal blood glucose levels across all the participants was not part of the study
design, but an undesired outcome that was only identified after the analysis of the raw CGM data
of several GDM participants. With this finding, having a measure of insulin resistance would
have been an appropriate comparison to look at what was occurring with underlying
physiological responses. However, as this characteristic was an undesired outcome, it wasn’t
considered when making decisions about other study measures. Overall, themethods applied in
this study were selected to capture glucose measures as practically and meaningfully as possible
in a non-invasive way; however, it is recognised that they are not equivalent to the clinical testing
procedures performed during pregnancy for screening and diagnosis of gestational diabetes.

Design-wise, this trial did not utilise a randomised or counter-balanced approach for the order of
the exercise trials between participants. While there were practical reasons for this decision, the
non-randomised study design may have also impacted the results, particularly with regards to
the impact of food intake and self-measured BGL calibrations during each phase, as participants
may have gotten better at maintaining their standardised diet, taking their BGLs and completing
their study diary second time around, being the discontinuous protocol. Similarly, it may have
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impacted ratings of perceived exertion and qualitative information on reported difficulty and
enjoyment of each protocol.
The heterogeneity of the groups is another factor that may have influenced study outcomes, with
regards to varying stages of gestation, body weight (pre-pregnancy), physical activity levels (pre
and during pregnancy), health conditions that also affect hormone and metabolic processes (such
as hypothyroid); and for the pregnancy group, the combination of normoglycaemic and GDM
women into the same study group. For non-pregnant women, other factors that may also
influence blood glucose responses, fatigue and metabolic measures such as prior pregnancy or
phase of menstruation cycle, were not captured or controlled within the current design.
However, an important focus of the pilot study was to investigate the effect of the exercise bouts
under relatively free-living conditions, rather than being strictly controlled and all other variables
standardised equally across all participants. One specific challenge in this design was matching
daily physical activity levels of occupational work. While this was controlled within an
individual’s trial to match work demands of Day 1 and Day 2, and in both phases wherever
possible, this was not always achieved.

5.6 General Conclusions
This study was conducted to investigate the effects of a single bout of discontinuous, moderate
intensity exercise on daily glycaemic control and acute blood glucose and cardiometabolic
responses, as a novel stimulus in pregnant women. The study was designed to compare these
responses to those following a bout of continuous, low intensity exercise of matched total work.
Additionally, the study measured responses to both exercise bouts in a group of non-pregnant
participants as a control. In pregnant women, a bout of discontinuous, moderate intensity
cycling had a different interaction for acute blood glucose changes in compared to continuous
exercise, yet both were positive and had significant reductions in blood glucose post-exercise.
However, the same responses were not found in the non-pregnant women, suggesting there may
be a difference in acute blood glucose responses following exercise in pregnant women,
compared to non-pregnant women. For pregnant women, discontinuous exercise offers a
practical and potentially effective option for short-term blood glucose reductions and was
reported to be more enjoyable for most women, compared to traditional continuous exercise.
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Daily glycaemic control was not affected by either type of exercise for either pregnant or nonpregnant women. When looking at the participants as a single group with normal blood glucose
levels, discontinuous exercise did have an overall significant effect on improving measures of
daily glucose variability, which was not observed for continuous exercise. This supports that
exercise intensity is an important factor for improving measures of daily glycaemic variability,
rather than only energy expenditure or overall duration of exercise. Differences observed in
measures of sympathetic and parasympathetic modulation between pregnant and non-pregnant
women relative to the type of exercise also reflect that either the exercise intensity, the
intermittent structure of the exercise (with intervals of rest), or a combination of the two have a
significant influence on relative sympathetic and parasympathetic balance during exercise in
pregnant women. Metabolic work, substrate utilisation and respiratory effort were not affected
by pregnancy condition during exercise or recovery for either type of exercise. However,
discontinuous exercise (when pooled) did demonstrate a shift towards higher carbohydrate
utilisation, which may be a contributing factor to the difference observed in daily glycaemic
variability following discontinuous, but not continuous exercise.

Based on the findings of this study, the first hypothesis, being ‘A bout of discontinuous,
moderate intensity cycling will elicit comparable acute glycaemic effects to a bout of continuous,
low intensity cycling of matched total work in pregnant women; with similar responses observed
in the non-pregnant control group’, is rejected. While there were similar acute blood glucose
reductions following both exercise protocols in pregnant women, there was a different
interaction found between the acute responses in pregnant compared to non-pregnant women,
where the responses were not the same.

For the second hypothesis, ‘a bout of discontinuous, moderate intensity cycling will elicit
different cardiometabolic responses during exercise and in the immediate post-exercise recovery
period in pregnant women, compared with continuous, low intensity exercise’, this would be
accepted, as there were significant differences observed in time (RMSSD) and frequency (Low
Frequency – absolute power) responses to the exercise protocols in pregnant women, and also
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when compared to non-pregnant women. However, these were the only significant responses
identified, with no other changes observed in the remaining HRV measures, or with exercising
oxygen consumption, respiratory exchange ratio or minute ventilation.

For the third hypothesis, ‘In pregnant women, a bout of discontinuous, moderate intensity
cycling will reduce 24-hour blood glucose levels and variability after exercise compared with 24hours preceding exercise. Comparatively, there will be no effect observed in pregnant women
following a bout of continuous, low intensity exercise; or in non-pregnant controls following
either discontinuous or continuous protocols’, this is rejected. There were no significant changes
found in any 24-hour blood glucose measures following either protocol in pregnant or nonpregnant women.

Lastly, the fourth hypothesis, ‘In participants with normal daily glycaemic levels, a bout of
discontinuous moderate intensity cycling will elicit comparable acute and 24-hour blood glucose
responses, compared to a bout of continuous, low intensity exercise of equal total work, but
double the volume of exercise’ is rejected. From the pooled data analysis, there were significant
differences observed in the effect on 24-hour mean blood glucose and glucose variability
following the discontinuous protocol, compared with the discontinuous protocol.

This novel pilot study has investigated the application of utilising interval exercise (described as
discontinuous exercise in this thesis) at a moderate intensity to augment glycaemic control in
pregnancy. It was found that 15 minutes of moderate intensity exercise, performed in a
discontinuous nature, was effective at reducing acute blood glucose levels in both pregnant and
non-pregnant women, meaning that interval exercise performed at moderate intensity may be an
effective strategy for glycaemic effects. Further, it was well tolerated and enjoyed by participants
without any adverse responses, suggesting that it may provide a comfortable and safe way for
women to exercise at moderate intensities, in line with the pregnancy guidelines, without being
limited by physical size, physical activity levels or current fitness.
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The limitations of the study, in particular the small numbers and the design change from having
women with gestational diabetes as a separate group, make the findings and applications of this
work restricted. Future research in this area could replicate this original design of this study and
include a GDM group to be able to truly evaluate the discontinuous exercise protocol for effect in
managing 24-hour glycaemic control in women with overt hyperglycaemia. Future studies will
also be able to confidently set the intensity protocols at less conservative levels, now that there
are updated current pregnancy and exercise guidelines to support the safety and the
effectiveness of moderate intensity exercise for all women with uncomplicated pregnancies.
Lastly, it would be very interesting to gain a better understanding of the normal daily glycaemic
profile in pregnant women, and in particular compare those who regularly exercise with those
who are inactive to quantify how free-living physical activity patterns affect daily glycaemic
control.

In conclusion, discontinuous, moderate intensity exercise totalling 15 minutes was equivalent to
30 minutes of continuous, low intensity exercise for beneficial effects on acute BGL response in
pregnant participants. However, neither bout resulted in changes to daily blood glucose control.
Further research is needed to identify discontinuous dose that augments daily glycaemic control
in pregnancy.
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APPENDIX 3

CSEP approved Sept 12 2011 version

PAR-Q+

The Physical Activity Readiness Questionnaire for Everyone
Regular physical activity is fun and healthy, and more people should become more physically active every day of the week.
Being more physically active is very safe for MOST people. This questionnaire will tell you whether it is necessary for you to
seek further advice from your doctor OR a qualified exercise professional before becoming more physically active.

SECTION 1 - GENERAL HEALTH
Please read the 7 questions below carefully and answer each one honestly: check YES or NO.

YES

NO





1. Has your doctor ever said that you have a heart condition OR high blood pressure?
2.

Do you feel pain in your chest at rest, during your daily activities of living, OR when you do physical
activity?





3.

Do you lose balance because of dizziness OR have you lost consciousness in the last 12 months? Please
answer NO if your dizziness was associated with over-breathing (including during vigorous exercise).





4.

Have you ever been diagnosed with another chronic medical condition
(other than heart disease or high blood pressure)?





5. Are you currently taking prescribed medications for a chronic medical condition?





Do you have a bone or joint problem that could be made worse by becoming more physically active?
6. Please answer NO if you had a joint problem in the past, but it does not limit your current ability to be
physically active. For example, knee, ankle, shoulder or other.





7. Has your doctor ever said that you should only do medically supervised physical activity?





If you answered NO to all of the questions above, you are cleared for physical activity.



Go to Section 3 to sign the form. You do not need to complete Section 2.

›› Start becoming much more physically active – start slowly and build up gradually.
›› Follow the Canadian Physical Activity Guidelines for your age (www.csep.ca/guidelines).
›› You may take part in a health and fitness appraisal.
›› If you have any further questions, contact a qualified exercise professional such as a
››



!

CSEP Certified Exercise Physiologist® (CSEP-CEP) or CSEP Certified Personal Trainer®
(CSEP-CPT).
If you are over the age of 45 yrs. and NOT accustomed to regular vigorous physical activity,
please consult a qualified exercise professional (CSEP-CEP) before engaging in maximal effort
exercise.

If you answered YES to one or more of the questions above, please GO TO SECTION 2.

Delay becoming more active if:
›› You are not feeling well because of a temporary illness such as a cold or fever – wait until you
feel better
›› You are pregnant – talk to your health care practitioner, your physician, a qualified exercise
professional, and/or complete the PARmed-X for Pregnancy before becoming more physically
active OR
›› Your health changes – please answer the questions on Section 2 of this document and/or talk to
your doctor or qualified exercise professional (CSEP-CEP or CSEP-CPT) before continuing with
any physical activity programme.
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SECTION 2 - CHRONIC MEDICAL CONDITIONS
Please read the questions below carefully and answer each one honestly: check YES or NO.

YES

NO





If yes, answer
questions
1a-1c

If no, go to
question 2

Do you have difficulty controlling your condition with medications or other
1a. physician-prescribed therapies? (Answer NO if you are not currently taking
medications or other treatments)





Do you have joint problems causing pain, a recent fracture or fracture caused
by osteoporosis or cancer, displaced vertebra (e.g., spondylolisthesis), and/
1b.
or spondylolysis/pars defect (a crack in the bony ring on the back of the spinal
column)?









1. Do you have Arthritis, Osteoporosis, or Back Problems?

1c.

Have you had steroid injections or taken steroid tablets regularly for more than 3
months?





If yes, answer
questions
2a-2b

If no, go to
question 3

Does your cancer diagnosis include any of the following types: lung/bronchogenic,
multiple myeloma (cancer of plasma cells), head, and neck?





2b. Are you currently receiving cancer therapy (such as chemotherapy or radiotherapy)?





2. Do you have Cancer of any kind?

2a.

Do you have Heart Disease or Cardiovascular Disease?
3. This includes Coronary Artery Disease, High Blood Pressure, Heart Failure, Diagnosed
Abnormality of Heart Rhythm
Do you have difficulty controlling your condition with medications or other
3a. physician-prescribed therapies?
(Answer NO if you are not currently taking medications or other treatments)
3b.

Do you have an irregular heart beat that requires medical management?
(e.g. atrial brillation, premature ventricular contraction)

3c. Do you have chronic heart failure?





If yes, answer
questions
3a-3e

If no, go to
question 4













3d.

Do you have a resting blood pressure equal to or greater than 160/90 mmHg with or
without medication? (Answer YES if you do not know your resting blood pressure)





3e.

Do you have diagnosed coronary artery (cardiovascular) disease and have not
participated in regular physical activity in the last 2 months?









If yes, answer
questions
4a-4c

If no, go to
question 5

4a. Is your blood sugar often above 13.0 mmol/L? (Answer YES if you are not sure)





Do you have any signs or symptoms of diabetes complications such as heart
4b. or vascular disease and/or complications affecting your eyes, kidneys, and the
sensation in your toes and feet?









4. Do you have any Metabolic Conditions?
This includes Type 1 Diabetes, Type 2 Diabetes, Pre-Diabetes

4c.

Do you have other metabolic conditions (such as thyroid disorders, pregnancyrelated diabetes, chronic kidney disease, liver problems)?





If yes, answer
questions
5a-5b

If no, go to
question 6

Do you have difficulty controlling your condition with medications or other
5a. physician-prescribed therapies? (Answer NO if you are not currently taking
medications or other treatments)





5b. Do you also have back problems affecting nerves or muscles?





Do you have any Mental Health Problems or Learning Difficulties?
5. This includes Alzheimer’s, Dementia, Depression, Anxiety Disorder, Eating Disorder,
Psychotic Disorder, Intellectual Disability, Down Syndrome)
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Please read the questions below carefully and answer each one honestly: check YES or NO.

YES

NO





If yes, answer
questions
6a-6d

If no, go to
question 7









If asthmatic, do you currently have symptoms of chest tightness, wheezing, laboured
6c. breathing, consistent cough (more than 2 days/week), or have you used your rescue
medication more than twice in the last week?





Has your doctor ever said you have high blood pressure in the blood vessels of your
lungs?





Do you have a Respiratory Disease?
6. This includes Chronic Obstructive Pulmonary Disease, Asthma, Pulmonary High Blood
Pressure
Do you have difficulty controlling your condition with medications or other
6a. physician-prescribed therapies?
(Answer NO if you are not currently taking medications or other treatments)
6b.

6d.

Has your doctor ever said your blood oxygen level is low at rest or during exercise
and/or that you require supplemental oxygen therapy?

7. Do you have a Spinal Cord Injury? This includes Tetraplegia and Paraplegia
Do you have difficulty controlling your condition with medications or other
7a. physician-prescribed therapies?
(Answer NO if you are not currently taking medications or other treatments)





If yes, answer
questions
7a-7c

If no, go to
question 8





7b.

Do you commonly exhibit low resting blood pressure significant enough to cause
dizziness, light-headedness, and/or fainting?





7c.

Has your physician indicated that you exhibit sudden bouts of high blood pressure
(known as Autonomic Dysreflexia)?









If yes, answer
questions
8a-c

If no, go to
question 9

Do you have difficulty controlling your condition with medications or other
8a. physician-prescribed therapies?
(Answer NO if you are not currently taking medications or other treatments)





8b. Do you have any impairment in walking or mobility?









8. Have you had a Stroke?
This includes Transient Ischemic Attack (TIA) or Cerebrovascular Event

8c.

Have you experienced a stroke or impairment in nerves or muscles in the past 6
months?

9. Do you have any other medical condition not listed above or do you live with two chronic
conditions?
Have you experienced a blackout, fainted, or lost consciousness as a result of a head
9a. injury within the last 12 months OR have you had a diagnosed concussion within the
last 12 months?
9b.

Do you have a medical condition that is not listed
(such as epilepsy, neurological conditions, kidney problems)?

9c. Do you currently live with two chronic conditions?





If yes, answer
questions
9a-c

If no, read
the advice
on page 4













Please proceed to Page 4 for recommendations for your current medical condition and sign this document.
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PAR-Q+
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If you answered NO to all of the follow-up questions about your medical condition, you are ready to
become more physically active:
›› It is advised that you consult a qualified exercise professional (e.g., a CSEP-CEP or CSEP-CPT) to help
you develop a safe and effective physical activity plan to meet your health needs.
›› You are encouraged to start slowly and build up gradually – 20-60 min. of low- to moderate-intensity
exercise, 3-5 days per week including aerobic and muscle strengthening exercises.
›› As you progress, you should aim to accumulate 150 minutes or more of moderate-intensity physical
activity per week.
›› If you are over the age of 45 yrs. and NOT accustomed to regular vigorous physical activity, please
consult a qualified exercise professional (CSEP-CEP) before engaging in maximal effort exercise.
If you answered YES to one or more of the follow-up questions about your medical condition:
›› You should seek further information from a licensed health care professional before becoming more
physically active or engaging in a fitness appraisal and/or visit a or qualified exercise professional
(CSEP-CEP) for further information.
Delay becoming more active if:
›› You are not feeling well because of a temporary illness such as a cold or fever – wait until you feel better
›› You are pregnant - talk to your health care practitioner, your physician, a qualified exercise profesional,
and/or complete the PARmed-X for Pregnancy before becoming more physically active OR
›› Your health changes - please talk to your doctor or qualified exercise professional (CSEP-CEP) before
continuing with any physical activity programme.

SECTION 3 - DECLARATION
›› You are encouraged to photocopy the PAR-Q+. You must use the entire questionnaire and NO changes are permitted.
›› The Canadian Society for Exercise Physiology, the PAR-Q+ Collaboration, and their agents assume no liability for persons
who undertake physical activity. If in doubt after completing the questionnaire, consult your doctor prior to physical activity.

›› If you are less than the legal age required for consent or require the assent of a care provider, your parent, guardian or care
provider must also sign this form.

›› Please read and sign the declaration below:
I, the undersigned, have read, understood to my full satisfaction and completed this questionnaire. I acknowledge that
this physical activity clearance is valid for a maximum of 12 months from the date it is completed and becomes invalid
if my condition changes. I also acknowledge that a Trustee (such as my employer, community/fitness centre, health
care provider, or other designate) may retain a copy of this form for their records. In these instances, the Trustee will be
required to adhere to local, national, and international guidelines regarding the storage of personal health information
ensuring that they maintain the privacy of the information and do not misuse or wrongfully disclose such information.

NAME ____________________________________________________ DATE _________________________________________
SIGNATURE _____________________________________WITNESS _________________________________________________
SIGNATURE OF PARENT/GUARDIAN/CARE PROVIDER _________________________________________________________
For more information, please contact:
Canadian Society for Exercise Physiology
www.csep.ca
KEY REFERENCES
1. Jamnik VJ, Warburton DER, Makarski J, McKenzie DC, Shephard RJ, Stone J, and Gledhill N. Enhancing the
eectiveness of clearance for physical activity participation; background and overall process. APNM 36(S1):S3S13, 2011.
2. Warburton DER, Gledhill N, Jamnik VK, Bredin SSD, McKenzie DC, Stone J, Charlesworth S, and Shephard RJ.
Evidence-based risk assessment and recommendations for physical activity clearance; Consensus Document.
APNM 36(S1):S266-s298, 2011.

The PAR-Q+ was created using the evidencebased AGREE process (1) by the PARQ+Collaboration chaired by Dr. Darren E.
R. Warburton with Dr. Norman Gledhill, Dr.
Veronica Jamnik, and Dr. Donald C. McKenzie
(2). Production of this document has been made
possible through financial contributions from
the Public Health Agency of Canada and the BC
Ministry of Health Services. The views expressed
herein do not necessarily represent the views
of the Public Health Agency of Canada or BC
Ministry of Health Services.
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APPENDIX 4

ACTIVITY READINESS
PARmed-X for PREGNANCY PHYSICAL
MEDICAL EXAMINATION

PARmed-X for PREGNANCY is a guideline for health screening
prior to participation in a prenatal fitness class or other exercise.
Healthy women with uncomplicated pregnancies can integrate physical activity into their daily living and can participate without significant risks either to
themselves or to their unborn child. Postulated benefits of such programs include improved aerobic and muscular fitness, promotion of appropriate weight
gain, and facilitation of labour. Regular exercise may also help to prevent gestational glucose intolerance and pregnancy-induced hypertension.
The safety of prenatal exercise programs depends on an adequate level of maternal-fetal physiological reserve. PARmed-X for PREGNANCY is a convenient
checklist and prescription for use by health care providers to evaluate pregnant patients who want to enter a prenatal fitness program and for ongoing medical
surveillance of exercising pregnant patients.
Instructions for use of the 4-page PARmed-X for PREGNANCY are the following:
1.

The patient should fill out the section on PATIENT INFORMATION and the PRE-EXERCISE HEALTH CHECKLIST (PART 1, 2, 3, and 4 on p. 1) and give
the form to the health care provider monitoring her pregnancy.

2.

The health care provider should check the information provided by the patient for accuracy and fill out SECTION C on CONTRAINDICATIONS (p. 2) based
on current medical information.

3.

If no exercise contraindications exist, the HEALTH EVALUATION FORM (p. 3) should be completed, signed by the health care provider, and given by the
patient to her prenatal fitness professional.

In addition to prudent medical care, participation in appropriate types, intensities and amounts of exercise is recommended to increase the likelihood of a beneficial
pregnancy outcome. PARmed-X for PREGNANCY provides recommendations for individualized exercise prescription (p. 3) and program safety (p. 4).

NOTE:

A

Sections A and B should be completed by the patient before the appointment with the health care provider.

PATIENT INFORMATION

NAME_____________________________________________________________________________________________________________________________________
ADDRESS__________________________________________________________________________________________________________________________________
TELEPHONE_______________________________ BIRTHDATE_______________________HEALTH INSURANCE No.___________________________________________
NAME OF
PRENATAL FITNESS
PRENATAL FITNESS PROFESSIONAL___________________________________________PROFESSIONAL’S PHONE NUMBER__________________________________

B PRE-EXERCISE HEALTH CHECKLIST
PART 1: GENERAL HEALTH STATUS

In the past, have you experienced (check YES or NO):
1. Miscarriage in an earlier pregnacy?
2. Other pregnancy complications?
3. I have completed a PAR-Q within the last 30 days.
If you answered YES to question 1 or 2, please explain:

1.

List only regular fitness/recreational activities:
_____________________________________________________

YES




NO




__________________________________________________________
Number of previous pregnancies?

PART 3: ACTIVITY HABITS DURING THE PAST MONTH

_____________________________________________________
INTENSITY
Heavy
Medium
Light
2.

________

PART 2: STATUS OF CURRENT PREGNANCY
Due Date:_________________________________________________
During this pregnancy, have you experienced:

YES
1. Marked fatigue?

2. Bleeding from the vagina (“spotting”)?

3. Unexplained faintness or dizziness?

4. Unexplained abdominal pain?

5. Sudden swelling of ankles, hands or face?

6. Persistent headaches or problems with headaches?

7. Swelling, pain or redness in the calf of one leg?

8. Absence of fetal movement after 6th month?

9. Failure to gain weight after 5th month?

If you answered YES to any of the above questions, please explain:

NO










_________________________________________________________
© 2013, Canadian Society for Exercise Physiology

3.
4.

FREQUENCY
(times/week)

1-2
____
____
____

2-4
____
____
____

4+
____
____
____

TIME

(minutes/day)

<20
____
____
____

20-40 40+
____ ____
____ ____
____ ____

Does your regular occupation (job/home) activity involve:
YES
Heavy Lifting?
Frequent walking/stair climbing?
Occasional walking (>once/hr)?
Prolonged standing?
Mainly sitting?
Normal daily activity?
Do you currently smoke tobacco?*
Do you consume alcohol?*










NO









PART 4: PHYSICAL ACTIVITY INTENTIONS
What physical activity do you intend to do?
_________________________________________________________
Is this a change from what you currently do?

 YES

 NO

*NOTE: PREGNANT WOMEN ARE STRONGLY ADVISED NOT TO SMOKE
OR CONSUME ALCOHOL DURING PREGNANCY AND DURING LACTATION.
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PARmed-X for PREGNANCY
C

CONTRAINDICATIONS TO EXERCISE: to be completed by your health care provider
Absolute Contraindications

Relative Contraindications

Does the patient have:

YES


1. Ruptured membranes, premature labour?

Does the patient have:

NO


2. Persistent second or third trimester
bleeding/placenta previa?





3. Pregnancy-induced hypertension or pre-eclampsia?





4. Incompetent cervix?





5. Evidence of intrauterine growth restriction?





6. High-order pregnancy (e.g., triplets)?





7. Uncontrolled Type I diabetes, hypertension or
thyroid disease, other serious cardiovascular,
respiratory or systemic disorder?



NO





2. Mild/moderate cardiovascular or respiratory disease
(e.g., chronic hypertension, asthma)?





3. Anemia or iron deficiency? (Hb < 100 g/L)?





4. Malnutrition or eating disorder (anorexia, bulimia)?





5. Twin pregnancy after 28th week?





6. Other significant medical condition?





Please specify:____________________________________________



PHYSICAL ACTIVITY RECOMMENDATION:

YES

1. History of spontaneous abortion or premature labour
in previous pregnancies?

NOTE:
Risk may exceed benefits of regular physical activity. The decision to
be physically active or not should be made with qualified medical advice.

 Recommended/Approved

 Contraindicated

Prescription for Aerobic Activity
RATE OF PROGRESSION: The best time to progress is during the second
trimester since risks and discomforts of pregnancy are lowest at that time.
Aerobic exercise should be increased gradually during the second trimester
from a minimum of 15 minutes per session, 3 times per week (at the appropriate
target heart rate or RPE to a maximum of approximately 30 minutes per session,
4 times per week (at the appropriate target heart rate or RPE).
WARM-UP/COOL-DOWN: Aerobic activity should be preceded by a brief
(10-15 min.) warm-up and followed by a short (10-15 min.) cool-down. Low
intensity calesthenics, stretching and relaxation exercises should be included
in the warm-up/cool-down.

F

FREQUENCY
Begin at 3 times
per week and
progress to
four times
per week

I

T

T

Exercise within
an appropriate
RPE range
and/or target
heart rate
zone

Attempt 15
minutes, even
if it means
reducing the
intensity.
Rest intervals
may be helpful

Non weight-bearing
or low-impact endurance
exercise using large
muscle groups (e.g.,
walking, stationary
cycling, swimming,
aquatic exercises, low
impact aerobics)

INTENSITY

TIME

PRESCRIPTION/MONITORING OF INTENSITY: The best way to prescribe
and monitor exercise is by combining the heart rate and rating of perceived
exertion (RPE) methods.
RATING OF
PERCEIVED
EXERTION (RPE)
HEART RATE RANGES FOR PREGNANT
WOMEN
MATERNAL
AGE
Less than
20
20–29

TYPE

“TALK TEST” - A final check to avoid overexertion is to use the “talk test”. The
exercise intensity is excessive if you cannot carry on a verbal conversation
while exercising.

FITNESS
LEVEL or BMI

30–39

HEART RATE
RANGE
(beats/minute)

-

140-155

Low
Active
Fit
BMI>25 kg m-2

129-144
135-150
145-160
102-124

Low
Active
Fit
BMI>25 kg m-2

128-144
130-145
140-156
101-120

Target HR ranges were derived from peak
exercise tests in medically prescreened low-risk
women who were pregnant. (Mottola et al., 2006;
Davenport et al., 2008).

Check the accuracy of
your heart rate target
zone by comparing it
to the scale below. A
range of about 12-14
(somewhat hard) is
appropriate for most
pregnant women.
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Very, very light
Somewhat light
Fairly light
Somewhat hard
Hard
Very hard
Very, very hard

The original PARmed-X for PREGNANCY was developed by L.A. Wolfe, Ph.D., Queen’s University and updated by Dr. M.F. Mottola, Ph.D., University of Western
Ontario.

No changes permitted. Translation and reproduction in its entirety is encouraged.

Disponible en français sous le titre «Examination medicale sur l’aptitude à l’activité physique pour les femmes enceintes (X-AAP pour les femmes enceintes)»
Additional copies of the PARmed-X for PREGNANCY, can be downloaded from
Canadian Society for Exercise Physiology
www.csep.ca/forms
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PARmed-X for PREGNANCY MEDICAL EXAMINATION
Prescription for Muscular Conditioning
It is important to condition all
major muscle groups during
both prenatal and postnatal
periods.
WARM-UPS & COOL DOWN:
Range of Motion: neck, shoulder girdle, back, arms, hips,
knees, ankles, etc.

Static Stretching: all major
muscle groups
(DO NOT OVER STRETCH!)

EXAMPLES OF MUSCULAR STRENGTHENING EXERCISES
category

purpose

example

Upper back

Promotion of good posture

Shoulder shrugs, shoulder blade pinch

Lower back

Promotion of good posture

Modified standing opposite leg & arm lifts

Abdomen

Promotion of good posture,
prevent low-back pain, prevent
diastasis recti, strengthen muscles of labour

Abdominal tightening, abdominal
curl-ups, head raises lying on side or standing position

Pelvic floor
(“Kegels”)

Promotion of good bladder control,
prevention of urinary incontinence

“Wave”, “elevator”

Upper body

Improve muscular support for breasts

Shoulder rotations, modified push-ups against a wall

Buttocks,
lower limbs

Facilitation of weight-bearing, prevention
of varicose veins

Buttocks squeeze,standing leg lifts, heel raises

PRECAUTIONS FOR MUSCULAR CONDITIONING DURING PREGNANCY
VARIABLE

EFFECTS OF PREGNANCY

Body Position

Joint Laxity
Abdominal Muscles

Posture

Precautions
for
Resistance Exercise

EXERCISE MODIFICATIONS

• in the supine position (lying on the back), the enlarged uterus
may either decrease the flow of blood returning from the lower
half of the body as it presses on a major vein (inferior vena cava)
or it may decrease flow to a major artery (abdominal aorta)

• past 4 months of gestation, exercises normally done in the
supine position should be altered
• such exercises should be done side lying or standing

• ligaments become relaxed due to increasing hormone levels
• joints may be prone to injury

• avoid rapid changes in direction and bouncing during exercises
• stretching should be performed with controlled movements

• presence of a rippling (bulging) of connective tissue along the
midline of the pregnant abdomen (diastasis recti) may be seen
during abdominal exercise

• abdominal exercises are not recommended if diastasis recti
develops

• increasing weight of enlarged breasts and uterus may cause a
forward shift in the centre of gravity and may increase the arch in
the lower back
• this may also cause shoulders to slump forward

• emphasis on correct posture and neutral pelvic alignment.
Neutral pelvic alignment is found by bending the knees,
feet shoulder width apart, and aligning the pelvis between
accentuated lordosis and the posterior pelvic tilt position.

• emphasis must be placed on continuous breathing throughout exercise
• exhale on exertion, inhale on relaxation using high repetitions and low weights
• Valsalva Manoevre (holding breath while working against a resistance) causes a change in blood pressure and therefore
should be avoided
• avoid exercise in supine position past 4 months gestation


PARmed-X for Pregnancy - Health Evaluation Form
(to be completed and given to the prenatal fitness professional
after obtaining medical clearance to exercise)

I, ______________________________________ PLEASE PRINT (patient’s name), have discussed my plans to participate in physical
activity during my current pregnancy with my health care provider and I have obtained his/her approval to begin participation.
Signed:____________________________________________
(patient’s signature)

Date:_____________________________________________

HEALTH CARE PROVIDER’S COMMENTS:
Name of health care provider:__________________________________

________________________________________________________

Address:___________________________________________________

________________________________________________________

__________________________________________________________

________________________________________________________

Telephone:__________________________________________________

________________________________________________________
(health care provider’s signature)
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Advice for Active Living During Pregnancy
Pregnancy is a time when women can make beneficial changes in their health habits to protect and promote the healthy development
of their unborn babies. These changes include adopting improved eating habits, abstinence from smoking and alcohol intake, and
participating in regular moderate physical activity. Since all of these changes can be carried over into the postnatal period and beyond,
pregnancy is a very good time to adopt healthy lifestyle habits that are permanent by integrating physical activity with enjoyable healthy
eating and a positive self and body image.

Active Living:




see your doctor before
increasing your activity level
during pregnancy
exercise regularly but don’t
overexert

Healthy Eating:



the need for calories is higher (about 300 more per day)
than before pregnancy
follow Canada’s Food Guide to Healthy Eating and choose
healthy foods from the following groups: whole grain or
enriched bread or cereal, fruits and vegetables, milk and
milk products, meat, fish, poultry and alternatives

exercise with a pregnant friend
or join a prenatal exercise
program



drink 6-8 glasses of fluid, including water, each day

follow FITT principles modified
for pregnant women





salt intake should not be restricted





know safety considerations for
exercise in pregnancy

limit caffeine intake i.e., coffee, tea, chocolate, and
cola drinks



dieting to lose weight is not recommended during
pregnancy



Positive Self and
Body Image:


remember that it is normal
to gain weight during
pregnancy



accept that your body
shape will change during
pregnancy



enjoy your pregnancy as
a unique and meaningful
experience

For more detailed information and advice about pre- and postnatal exercise, you may wish to obtain a copy of a booklet entitled Active Living During
Pregnancy: Physical Activity Guidelines for Mother and Baby © 1999. Available from the Canadian Society for Exercise Physiology,
www.csep.ca. Cost: $11.95

Public Health Agency of Canada. The sensible guide to a healthy pregnancy. Minister of Health, 2012. Ottawa, Ontario K1A 0K9. http://www.phac-aspc.
gc.ca/hp-gs/guide/assets/pdf/hpguide-eng.pdf. HC Pub.: 5830 Cat.: HP5-33/2012E. 1 800 O-Canada (1-800-622-6232) TTY: 1-800-926-9105.
Davenport MH. Charlesworth S. Vanderspank D. Sopper MM. Mottola MF. Development and validation of exercise target heart rate zones for overweight and obese pregnant women. Appl Physiol Nutr Metab. 2008; 33(5): 984-9.
Davies GAL. Wolfe LA. Mottola MF. MacKinnon C. Joint SOGC / CSEP Clinical Practice Guidelines: Exercise in Pregnancy and the Postpartum
Period. Can J Appl Physiol. 2003; 28(3): 329-341.

Mottola MF, Davenport MH, Brun CR, Inglis SD, Charlesworth S, Sopper MM. VO2peak prediction and exercise prescription for pregnant women.
Med Sci Sports Exerc. 2006 Aug;38(8):1389-95.PMID: 16888450

SAFETY CONSIDERATIONS
 Avoid exercise in warm/humid environments, especially during
the 1st trimester
 Avoid isometric exercise or straining while holding your breath
 Maintain adequate nutrition and hydration — drink liquids
before and after exercise
 Avoid exercise while lying on your back past the 4th month of
pregnancy
 Avoid activities which involve physical contact or danger of
falling
 Know your limits — pregnancy is not a good time to train for
athletic competition
 Know the reasons to stop exercise and consult a
qualified health care provider immediately if they occur

REASONS TO STOP EXERCISE
AND CONSULT YOUR
HEALTH CARE PROVIDER
 Excessive shortness of breath
 Chest pain
 Painful uterine contractions (more than
6-8 per hour)
 Vaginal bleeding
 Any “gush” of fluid from vagina
(suggesting premature rupture of the
membranes)
 Dizziness or faintness
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